1
|
Rodríguez-Molino P, Tebruegge M, Noguera-Julian A, Neth O, Fidler K, Brinkmann F, Sainz T, Ivaskeviciene I, Ritz N, Brito MJ, Milheiro Silva T, Chechenieva V, Serdiuk M, Lancella L, Russo C, Soler-García A, Navarro ML, Krueger R, Feiterna-Sperling C, Starshinova A, Hiteva A, Hoffmann A, Kalibatas P, Lo Vecchio A, Scarano SM, Bustillo M, Blázquez Gamero D, Espiau M, Buonsenso D, Falcón L, Turnbull L, Colino E, Rueda S, Buxbaum C, Carazo B, Alvarez C, Dapena M, Piqueras A, Velizarova S, Ozere I, Götzinger F, Pareja M, Garrote Llanos MI, Soto B, Rodríguez Martín S, Korta JJ, Pérez-Gorricho B, Herranz M, Hernández-Bartolomé Á, Díaz-Almirón M, Kohns Vasconcelos M, Ferreras-Antolín L, Santiago-García B. Tuberculosis disease in immunocompromised children and adolescents: a pTBnet multi-centre case-control study. Clin Infect Dis 2024:ciae158. [PMID: 38568992 DOI: 10.1093/cid/ciae158] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/04/2024] [Revised: 03/06/2024] [Accepted: 03/08/2024] [Indexed: 04/05/2024] Open
Abstract
BACKGROUND In high-resource settings the survival of immunocompromised (IC) children has increased and immunosuppressive therapies are increasingly being used. This study aimed to determine the clinical characteristics, performance of diagnostic tools and outcome of IC children with TB in Europe. METHODS Multicentre, matched case-control study within the Paediatric Tuberculosis Network European Trials Group (ptbnet), capturing TB cases <18 years diagnosed 2000-2020. RESULTS 417 TB cases were included, comprising 139 children with IC (HIV, inborn errors of immunity, drug-induced immunosuppression and other immunocompromising conditions) and 278 non-IC children as controls. Non-respiratory TB was more frequent among cases than controls (32.4% vs. 21.2%; p = 0.013). IC patients had an increased likelihood of presenting with severe disease (57.6% vs. 38.5%; p < 0.001; OR [95% CI]: 2.073 [1.37-3.13]). Children with IC had higher rates of false-negative tuberculin skin test (31.9% vs. 6.0%; p < 0.001) and QuantiFERON-TB Gold assay (30.0% vs. 7.3%; p < 0.001) results at diagnosis. Overall, the microbiological confirmation rate was similar in IC and non-IC cases (58.3% vs. 49.3%; p = 0.083). Although the mortality in IC children was <1%, the rate of long-term sequelae was significantly higher than in non-IC cases (14.8% vs. 6.1%; p = 0.004). CONCLUSIONS IC children with TB disease in Europe have increased rates of non-respiratory TB, severe disease, and long-term sequelae. Immune-based TB tests have poor sensitivity in those children. Future research should focus on developing improved immunological TB tests that perform better in IC patients, and determining the reasons for the increased risk of long-term sequelae, with the aim to design preventive management strategies.
Collapse
Affiliation(s)
- Paula Rodríguez-Molino
- General Pediatrics, Infectious and Tropical Diseases Department, Hospital La Paz, Madrid, Spain. La Paz Research Institute (IdiPAZ), Madrid, Spain. Faculty of Medicine, Universidad Autónoma de Madrid (UAM), Madrid, Spain
- Centro de Investigación Biomédica en Red en Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain
| | - Marc Tebruegge
- Department of Paediatrics & National Reference Centre for Paediatric Tuberculosis, Klinik Ottakring, Wiener Gesundheitsverbund, Vienna, Austria
- Department of Paediatrics, University of Melbourne, Melbourne, Australia
- Great Ormond Street Institute of Child Health, Department of Infection, Immunity & Inflammation, University College London, London, United Kingdom
| | - Antoni Noguera-Julian
- Infectious Diseases and Systemic Inflammatory Response in Pediatrics, Pediatric Infectious Diseases Department, Institut de Recerca Sant Joan de Déu, Barcelona, Spain
- Departament de Cirurgia i Especialitats Medicoquirúrgiques, Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona, Barcelona, Spain
- Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública, Instituto de Salud Carlos III, Madrid, Spain
| | - Olaf Neth
- Pediatric Infectious Diseases, Rheumatology and Immunology Unit, Hospital Universitario Virgen del Rocío, Instituto de Biomedicina de Sevilla, IBiS/Universidad de Sevilla/CSIC, Red de Investigación Traslacional en Infectología Pediátrica (RITIP) Seville, Spain
| | - Katy Fidler
- Paediatric Infectious Diseases Department, Royal Alexandra Children's Hospital, Brighton, United Kingdom
| | - Folke Brinkmann
- Department of Pediatric Pneumology, Allergology and CF Center, University Children's Hospital Bochum, Bochum, Germany
| | - Talia Sainz
- General Pediatrics, Infectious and Tropical Diseases Department, Hospital La Paz, Madrid, Spain. La Paz Research Institute (IdiPAZ), Madrid, Spain. Faculty of Medicine, Universidad Autónoma de Madrid (UAM), Madrid, Spain
- Centro de Investigación Biomédica en Red en Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain
| | - Inga Ivaskeviciene
- Clinic of Children's Diseases, Institute of Clinical Medicine, Vilnius University, Vilnius, Lithuania
| | - Nicole Ritz
- Department of Paediatrics & Paediatric Infectious Diseases, Children's Hospital of Central Switzerland, Lucerne, Switzerland. Mycobacterial and Migrant Health Research, University Children's Hospital Basel and Department for Clinical Research University of Basel, Basel, Switzerland
| | - Maria Joao Brito
- Infectious diseases Unit, Pediatrics department. Hospital Dona Estefânia. Centro Hospitalar e Universitário Lisboa Central. Lisboa. Portugal
| | - Tiago Milheiro Silva
- Infectious diseases Unit, Pediatrics department. Hospital Dona Estefânia. Centro Hospitalar e Universitário Lisboa Central. Lisboa. Portugal
| | - Vira Chechenieva
- Department of Paediatrics & National Reference Centre for Paediatric Tuberculosis, Klinik Ottakring, Wiener Gesundheitsverbund, Vienna, Austria
- Centre for Treatment Children with HIV/AIDS, National Specialised Children's Hospital "OKHMATDYT", Kyiv, Ukraine
- Pediatric TB Department, National institute of Phthisiology and Pulmonology named after F.G. Yanovsky NAMS of Ukraine, Kyiv, Ukraine
| | - Maryna Serdiuk
- Centre for Treatment Children with HIV/AIDS, National Specialised Children's Hospital "OKHMATDYT", Kyiv, Ukraine
| | - Laura Lancella
- Virology and Mycobacteria Unit, Bambino Gesù Children's Hospital, Rome, Italy
| | - Cristina Russo
- Virology and Mycobacteria Unit, Bambino Gesù Children's Hospital, Rome, Italy
| | - Aleix Soler-García
- Infectious Diseases and Systemic Inflammatory Response in Pediatrics, Pediatric Infectious Diseases Department, Institut de Recerca Sant Joan de Déu, Barcelona, Spain
| | - Maria Luisa Navarro
- Paediatric Infectious Diseases Department, Gregorio Marañón University Hospital, Madrid, Spain. UDIMIFFA, Gregorio Marañón Research Health Institute (IiSGM), UCM, Madrid, Spain
- Centro de Investigación Biomédica en Red en Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain
| | - Renate Krueger
- Department of Pediatric Respiratory Medicine, Immunology and Critical Care Medicine, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health (BIH), Berlin, Germany
| | - Cornelia Feiterna-Sperling
- Department of Pediatric Respiratory Medicine, Immunology and Critical Care Medicine, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health (BIH), Berlin, Germany
| | - Anna Starshinova
- St. Petersburg Research Institute of Phthisiopulmonology, Russia
| | - Antonina Hiteva
- St. Petersburg Research Institute of Phthisiopulmonology, Russia
| | - Anna Hoffmann
- Department of Pediatric Pneumology, Allergology and CF Center, University Children's Hospital Bochum, Bochum, Germany
| | - Paulius Kalibatas
- Clinic of Children's Diseases, Institute of Clinical Medicine, Vilnius University, Vilnius, Lithuania
| | - Andrea Lo Vecchio
- Pediatric Infectious Disease Unit, University Hospital Policlinico "Federico II" and Department of Translational Medical Sciences - Section of Pediatrics, University of Naples "Federico II", Italy
| | - Sara Maria Scarano
- Pediatric Infectious Disease Unit, University Hospital Policlinico "Federico II" and Department of Translational Medical Sciences - Section of Pediatrics, University of Naples "Federico II", Italy
| | - Matilde Bustillo
- Pediatrics Infectious Diseases Department, Hospital Universitario Miguel Servet, Zaragoza, Spain
| | - Daniel Blázquez Gamero
- Pediatric Infectious Diseases Unit, Department of Pediatrics, Hospital Universitario 12 de Octubre, Universidad Complutense, Madrid, Spain
| | - María Espiau
- Pediatric Infectious Diseases and Immunodeficiencies Unit, Hospital Universitari Vall d'Hebron, Vall d'Hebron Research Institute, Vall d'Hebron Barcelona Hospital Campus, Universitat Autònoma de Barcelona (UAB), Barcelona, Catalonia, Spain
| | - Danilo Buonsenso
- Department of Woman and Child Health and Public Health, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy
| | - Lola Falcón
- Pediatric Infectious Diseases, Rheumatology and Immunology Unit, Hospital Universitario Virgen del Rocío, Instituto de Biomedicina de Sevilla, IBiS/Universidad de Sevilla/CSIC, Red de Investigación Traslacional en Infectología Pediátrica (RITIP) Seville, Spain
| | | | - Elena Colino
- Pediatric Infectious Diseases Unit, Complejo Hospitalario Insular Materno Infantil Las Palmas, Las Palmas de Gran Canaria
| | - Santiago Rueda
- Department of Pediatrics, Hospital Universitario Clínico San Carlos, Madrid, Spain
| | - Charlotte Buxbaum
- Astrid Lindgren Children's Hospital, Karolinska University Hospital Huddinge, Stockholm, Sweden
| | - Begoña Carazo
- Pediatric Infectious Diseases and Immunodeficiencies Unit, Hospital Universitario Regional de Málaga, Málaga, Spain
| | - Cristina Alvarez
- Pediatrics Department, Marqués de Valdecilla University Hospital, Santander, Spain
| | - Marta Dapena
- Pediatric Infectious Diseases Unit, Hospital General de Castellón, Castellón, Spain
| | - Anabel Piqueras
- Pediatrics Department, Hospital Universitario La Fe, Valencia, Spain
| | - Svetlana Velizarova
- Children's Clinic, Department of Pulmonary Diseases, MHATLD "St Sofia", Medical University Sofia, Sofia, Bulgaria
| | - Iveta Ozere
- Centre of Tuberculosis and Lung Diseases of Riga Eastern Clinical University Hospital, Latvia
| | - Florian Götzinger
- Department of Paediatrics & National Reference Centre for Paediatric Tuberculosis, Klinik Ottakring, Wiener Gesundheitsverbund, Vienna, Austria
| | - Marta Pareja
- Pediatrics Department, Albacete University Hospital, Albacete, Spain
| | | | - Beatriz Soto
- Pediatrics Department, Getafe University Hospital, Getafe, Spain
| | - Sonia Rodríguez Martín
- Pediatrics Department, Príncipe de Asturias University Hospital, Alcalá de Henares, Spain. Medicine Department, Faculty of Medicine, University of Alcalá, Spain
| | - Jose Javier Korta
- Pediatrics Department, Donostia University Hospital, San Sebastián, Spain
| | - Beatriz Pérez-Gorricho
- Pediatric Infectious Diseases Unit, Department of Pediatrics, Hospital Infantil Universitario Niño Jesús, Madrid, Spain
| | - Mercedes Herranz
- Pediatrics Department, Navarra University Hospital, Navarra, Spain
| | - Ángel Hernández-Bartolomé
- Paediatric Infectious Diseases Department, Gregorio Marañón University Hospital, Madrid, Spain. UDIMIFFA, Gregorio Marañón Research Health Institute (IiSGM), UCM, Madrid, Spain
| | | | - Malte Kohns Vasconcelos
- Institute for Medical Biometry and Epidemiology, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany
| | - Laura Ferreras-Antolín
- Paediatric Infectious Diseases and Immunodeficiencies Unit. St. George's University Hospital, NHS Foundation Trust. London, United Kingdom
| | - Begoña Santiago-García
- Paediatric Infectious Diseases Department, Gregorio Marañón University Hospital, Madrid, Spain. UDIMIFFA, Gregorio Marañón Research Health Institute (IiSGM), UCM, Madrid, Spain
- Centro de Investigación Biomédica en Red en Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain
| |
Collapse
|
2
|
Martin-Broto J, Olarte-García A, Fernandéz-Rodríguez R, Ferreira MR, Carrasco-García I, Galvez-Montosa F, Rincon-Perez I, Peinado-Serrano J, Azinovic I, Guzman-Gomez L, Salgado L, Sevillano A, Ortega J, Alvarez C, Gutierrez A, Moura DS, Hindi N. Trabectedin and low-dose radiation therapy in patients with advanced leiomyosarcoma. Ther Adv Med Oncol 2024; 16:17588359231225044. [PMID: 38288156 PMCID: PMC10823838 DOI: 10.1177/17588359231225044] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/29/2023] [Accepted: 12/05/2023] [Indexed: 01/31/2024] Open
Abstract
Background and objectives Dimensional response is an unmet need in second lines of advanced soft tissue sarcomas (STS). Indeed, the three approved drugs, pazopanib, trabectedin, and eribulin, achieved an overall response rate (ORR) of less than 10%. This fact potentially hinders the options for fast symptomatic relief or surgical rescue. The combination of trabectedin plus low-dose radiation therapy (T-XRT) demonstrated a response rate of 60% in phase I/II trial, while real-life data achieved 32.5% ORR, probably due to a more relaxed timing between treatments. These results were obtained in progressing and advanced STS. In this study, the merged databases (trial plus real life) have been analyzed, with a special focus on leiomyosarcoma patients. Design and methods As responses were seen in a wide range of sarcoma histologies (11), this study planned to analyze whether leiomyosarcoma, the largest subtype with 26 cases (30.6%) in this series, exhibited a better clinical outcome with this therapeutic strategy. In addition, four advanced and progressing leiomyosarcoma patients, all with extraordinarily long progression-free survival of over 18 months, were collected. Results A total of 847 cycles of trabectedin were administered to 85 patients, with the median number of cycles per patient being 7 (1-45+). A trend toward a longer progression-free survival (PFS) was observed in leiomyosarcoma patients with median PFS (mPFS) of 9.9 months [95% confidence interval (CI): 1.1-18.7] versus 5.6 months (95% CI: 3.2-7.9) for the remaining histologies, p = 0.25. When leiomyosarcoma and liposarcoma were grouped, this difference reached statistical significance, probably due to the special sensitivity of myxoid liposarcoma. The mPFS for L-sarcomas was 12.7 months (95% CI: 7-18.5) versus 4.3 months (95% CI: 3.3-5.3) for the remaining histologies, p = 0.001. Cases with long-lasting disease control are detected among leiomyosarcoma patients. Conclusion Even when extraordinarily long-lasting responses do exist among leiomyosarcoma patients treated with T-XR, we were unable to demonstrate a significant difference favoring leiomyosarcoma patients in clinical outcomes.
Collapse
Affiliation(s)
- Javier Martin-Broto
- Medical Oncology Department, Fundación Jimenez Diaz University Hospital, Av. de los Reyes Católicos, 2, Madrid 28040, Spain
- University Hospital General de Villalba, Madrid, Spain
- Instituto de Investigación Sanitaria Fundación Jimenez Diaz, La Universidad Autónoma de Madrid, Madrid, Spain
| | - Alicia Olarte-García
- Radiation Oncology Service, Instituto Oncológico, Clínica IMQ Zorrotzaurre, Bilbao, Spain
| | | | - Marta Ribeiro Ferreira
- Medical Oncology Department, Instituto Português de Oncologia do Porto FG, Porto, Portugal
| | | | | | | | - Javier Peinado-Serrano
- Department of Radiation Oncology, University Hospital Virgen del Rocío, Sevilla, Spain
- Instituto de Biomedicina de Sevilla, Hospital Universitario Virgen del Rocío, Consejo Superior de Investigaciones Científicas, Universidad de Sevilla, Seville, Spain
- CIBERONC, Instituto de Salud Carlos III, Madrid, Spain
| | - Ignacio Azinovic
- Department of Radiation Oncology, Fundación Jimenez Diaz University Hospital, Madrid, Spain
| | - Laura Guzman-Gomez
- Department of Radiation Oncology, Fundación Jimenez Diaz University Hospital, Madrid, Spain
| | - Lurdes Salgado
- Radiotherapy Department, Instituto Português de Oncologia do Porto FG, Porto, Portugal
| | - Alberto Sevillano
- Medical Oncology Department, Fundación Jimenez Diaz University Hospital, Madrid, Spain
- University Hospital General de Villalba, Madrid, Spain
- Instituto de Investigación Sanitaria Fundación Jimenez Diaz, La Universidad Autónoma de Madrid, Madrid, Spain
| | - Justo Ortega
- Medical Oncology Department, Fundación Jimenez Diaz University Hospital, Madrid, Spain
- University Hospital General de Villalba, Madrid, Spain
- Instituto de Investigación Sanitaria Fundación Jimenez Diaz, La Universidad Autónoma de Madrid, Madrid, Spain
| | | | - Antonio Gutierrez
- Medical Hematology Department, Son Espases University Hospital, Mallorca, Spain
| | - David S. Moura
- Instituto de Investigación Sanitaria Fundación Jimenez Diaz, La Universidad Autónoma de Madrid, Madrid, Spain
| | - Nadia Hindi
- Medical Oncology Department, Fundación Jimenez Diaz University Hospital, Madrid, Spain
- University Hospital General de Villalba, Madrid, Spain
- Instituto de Investigación Sanitaria Fundación Jimenez Diaz, La Universidad Autónoma de Madrid, Madrid, Spain
| |
Collapse
|
3
|
Albert A, Alfaro R, Alvarez C, Arteaga-Velázquez JC, Avila Rojas D, Ayala Solares HA, Babu R, Belmont-Moreno E, Brisbois C, Caballero-Mora KS, Capistrán T, Carramiñana A, Casanova S, Chaparro-Amaro O, Cotti U, Cotzomi J, Coutiño de León S, De la Fuente E, Diaz Hernandez R, Dingus BL, DuVernois MA, Durocher M, Díaz-Vélez JC, Ellsworth RW, Engel K, Espinoza C, Fan KL, Fang K, Fernández Alonso M, Fleischhack H, Fraija N, García-González JA, Garfias F, González MM, Goodman JA, Harding JP, Hernandez S, Hinton J, Huang D, Hueyotl-Zahuantitla F, Hüntemeyer P, Iriarte A, Joshi V, Kaufmann S, Lee J, Linnemann JT, Longinotti AL, Luis-Raya G, Malone K, Martinez O, Martínez-Castro J, Matthews JA, Miranda-Romagnoli P, Morales-Soto JA, Moreno E, Mostafá M, Nayerhoda A, Nellen L, Nisa MU, Noriega-Papaqui R, Olivera-Nieto L, Omodei N, Pérez Araujo Y, Pérez-Pérez EG, Rho CD, Rosa-González D, Ruiz-Velasco E, Salazar H, Salazar-Gallegos D, Sandoval A, Schneider M, Serna-Franco J, Smith AJ, Son Y, Springer RW, Tibolla O, Tollefson K, Torres I, Torres-Escobedo R, Turner R, Ureña-Mena F, Varela E, Villaseñor L, Wang X, Watson IJ, Willox E, Yun-Cárcamo S, Zhou H, de León C, Beacom JF, Linden T, Ng KCY, Peter AHG, Zhou B. Discovery of Gamma Rays from the Quiescent Sun with HAWC. Phys Rev Lett 2023; 131:051201. [PMID: 37595214 DOI: 10.1103/physrevlett.131.051201] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/06/2022] [Revised: 01/27/2023] [Accepted: 06/23/2023] [Indexed: 08/20/2023]
Abstract
We report the first detection of a TeV γ-ray flux from the solar disk (6.3σ), based on 6.1 years of data from the High Altitude Water Cherenkov (HAWC) observatory. The 0.5-2.6 TeV spectrum is well fit by a power law, dN/dE=A(E/1 TeV)^{-γ}, with A=(1.6±0.3)×10^{-12} TeV^{-1} cm^{-2} s^{-1} and γ=3.62±0.14. The flux shows a strong indication of anticorrelation with solar activity. These results extend the bright, hard GeV emission from the disk observed with Fermi-LAT, seemingly due to hadronic Galactic cosmic rays showering on nuclei in the solar atmosphere. However, current theoretical models are unable to explain the details of how solar magnetic fields shape these interactions. HAWC's TeV detection thus deepens the mysteries of the solar-disk emission.
Collapse
Affiliation(s)
- A Albert
- Physics Division, Los Alamos National Laboratory, Los Alamos, NM 87544, USA
| | - R Alfaro
- Instituto de F'isica, Universidad Nacional Autónoma de México, Ciudad de Mexico, Mexico
| | - C Alvarez
- Universidad Autónoma de Chiapas, Tuxtla Gutiérrez, Chiapas, México
| | | | - D Avila Rojas
- Instituto de F'isica, Universidad Nacional Autónoma de México, Ciudad de Mexico, Mexico
| | - H A Ayala Solares
- Department of Physics, Pennsylvania State University, University Park, PA, USA
| | - R Babu
- Department of Physics, Michigan Technological University, Houghton, MI, USA
| | - E Belmont-Moreno
- Instituto de F'isica, Universidad Nacional Autónoma de México, Ciudad de Mexico, Mexico
| | - C Brisbois
- Department of Physics, University of Maryland, College Park, MD, USA
| | | | - T Capistrán
- Instituto de Astronom'ia, Universidad Nacional Autónoma de México, Ciudad de Mexico, Mexico
| | - A Carramiñana
- Instituto Nacional de Astrof'isica, Óptica y Electrónica, Puebla, Mexico
| | - S Casanova
- Instytut Fizyki Jadrowej im Henryka Niewodniczanskiego Polskiej Akademii Nauk, IFJ-PAN, Krakow, Poland
| | - O Chaparro-Amaro
- Centro de Investigaci'on en Computaci'on, Instituto Polit'ecnico Nacional, M'exico City, M'exico
| | - U Cotti
- Universidad Michoacana de San Nicolás de Hidalgo, Morelia, Mexico
| | - J Cotzomi
- Facultad de Ciencias F'isico Matemáticas, Benemérita Universidad Autónoma de Puebla, Puebla, Mexico
| | - S Coutiño de León
- Department of Physics, University of Wisconsin-Madison, Madison, WI, USA
| | - E De la Fuente
- Departamento de F'isica, Centro Universitario de Ciencias Exactase Ingenierias, Universidad de Guadalajara, Guadalajara, Mexico
| | - R Diaz Hernandez
- Instituto Nacional de Astrof'isica, Óptica y Electrónica, Puebla, Mexico
| | - B L Dingus
- Physics Division, Los Alamos National Laboratory, Los Alamos, NM 87544, USA
- Department of Physics, University of Maryland, College Park, MD, USA
| | - M A DuVernois
- Department of Physics, University of Wisconsin-Madison, Madison, WI, USA
| | - M Durocher
- Physics Division, Los Alamos National Laboratory, Los Alamos, NM 87544, USA
| | - J C Díaz-Vélez
- Departamento de F'isica, Centro Universitario de Ciencias Exactase Ingenierias, Universidad de Guadalajara, Guadalajara, Mexico
| | - R W Ellsworth
- Department of Physics, University of Maryland, College Park, MD, USA
| | - K Engel
- Department of Physics, University of Maryland, College Park, MD, USA
| | - C Espinoza
- Instituto de F'isica, Universidad Nacional Autónoma de México, Ciudad de Mexico, Mexico
| | - K L Fan
- Department of Physics, University of Maryland, College Park, MD, USA
| | - K Fang
- Department of Physics, University of Wisconsin-Madison, Madison, WI, USA
| | - M Fernández Alonso
- Department of Physics, Pennsylvania State University, University Park, PA, USA
| | - H Fleischhack
- Department of Physics, Catholic University of America, 620 Michigan Avenue NE, Washington, DC 20064
- NASA Goddard Space Flight Center, Greenbelt, MD 20771, USA
- Center for Research and Exploration in Space Science and Technology, NASA/GSFC, Greenbelt, MD 20771
| | - N Fraija
- Instituto de Astronom'ia, Universidad Nacional Autónoma de México, Ciudad de Mexico, Mexico
| | - J A García-González
- Tecnologico de Monterrey, Escuela de Ingeniería y Ciencias, Avenue Eugenio Garza Sada 2501, Monterrey, N.L., Mexico, 64849
| | - F Garfias
- Instituto de Astronom'ia, Universidad Nacional Autónoma de México, Ciudad de Mexico, Mexico
| | - M M González
- Instituto de Astronom'ia, Universidad Nacional Autónoma de México, Ciudad de Mexico, Mexico
| | - J A Goodman
- Department of Physics, University of Maryland, College Park, MD, USA
| | - J P Harding
- Physics Division, Los Alamos National Laboratory, Los Alamos, NM 87544, USA
| | - S Hernandez
- Instituto de F'isica, Universidad Nacional Autónoma de México, Ciudad de Mexico, Mexico
| | - J Hinton
- Max-Planck Institute for Nuclear Physics, 69117 Heidelberg, Germany
| | - D Huang
- Department of Physics, Michigan Technological University, Houghton, MI, USA
| | | | - P Hüntemeyer
- Department of Physics, Michigan Technological University, Houghton, MI, USA
| | - A Iriarte
- Instituto de Astronom'ia, Universidad Nacional Autónoma de México, Ciudad de Mexico, Mexico
| | - V Joshi
- Erlangen Centre for Astroparticle Physics, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany
| | - S Kaufmann
- Universidad Politecnica de Pachuca, Pachuca, Hgo, Mexico
| | - J Lee
- University of Seoul, Seoul, Rep. of Korea
| | - J T Linnemann
- Department of Physics and Astronomy, Michigan State University, East Lansing, MI, USA
| | - A L Longinotti
- Instituto de Astronom'ia, Universidad Nacional Autónoma de México, Ciudad de Mexico, Mexico
| | - G Luis-Raya
- Universidad Politecnica de Pachuca, Pachuca, Hgo, Mexico
| | - K Malone
- Space Science and Applications Group, Los Alamos National Laboratory, Los Alamos, NM 87544, USA
| | - O Martinez
- Facultad de Ciencias F'isico Matemáticas, Benemérita Universidad Autónoma de Puebla, Puebla, Mexico
| | - J Martínez-Castro
- Centro de Investigaci'on en Computaci'on, Instituto Polit'ecnico Nacional, M'exico City, M'exico
| | - J A Matthews
- Dept of Physics and Astronomy, University of New Mexico, Albuquerque, NM, USA
| | | | - J A Morales-Soto
- Universidad Michoacana de San Nicolás de Hidalgo, Morelia, Mexico
| | - E Moreno
- Facultad de Ciencias F'isico Matemáticas, Benemérita Universidad Autónoma de Puebla, Puebla, Mexico
| | - M Mostafá
- Department of Physics, Pennsylvania State University, University Park, PA, USA
| | - A Nayerhoda
- Instytut Fizyki Jadrowej im Henryka Niewodniczanskiego Polskiej Akademii Nauk, IFJ-PAN, Krakow, Poland
| | - L Nellen
- Instituto de Ciencias Nucleares, Universidad Nacional Autónoma de Mexico, Ciudad de Mexico, Mexico
| | - M U Nisa
- Department of Physics and Astronomy, Michigan State University, East Lansing, MI, USA
| | | | - L Olivera-Nieto
- Max-Planck Institute for Nuclear Physics, 69117 Heidelberg, Germany
| | - N Omodei
- Department of Physics, Stanford University: Stanford, CA 94305-4060, USA
| | - Y Pérez Araujo
- Instituto de Astronom'ia, Universidad Nacional Autónoma de México, Ciudad de Mexico, Mexico
| | | | - C D Rho
- Department of Physics, Sungkyunkwan University, Suwon 16419, South Korea
| | - D Rosa-González
- Instituto Nacional de Astrof'isica, Óptica y Electrónica, Puebla, Mexico
| | - E Ruiz-Velasco
- Max-Planck Institute for Nuclear Physics, 69117 Heidelberg, Germany
| | - H Salazar
- Facultad de Ciencias F'isico Matemáticas, Benemérita Universidad Autónoma de Puebla, Puebla, Mexico
| | - D Salazar-Gallegos
- Department of Physics and Astronomy, Michigan State University, East Lansing, MI, USA
| | - A Sandoval
- Instituto de F'isica, Universidad Nacional Autónoma de México, Ciudad de Mexico, Mexico
| | - M Schneider
- Department of Physics, University of Maryland, College Park, MD, USA
| | - J Serna-Franco
- Instituto de F'isica, Universidad Nacional Autónoma de México, Ciudad de Mexico, Mexico
| | - A J Smith
- Department of Physics, University of Maryland, College Park, MD, USA
| | - Y Son
- University of Seoul, Seoul, Rep. of Korea
| | - R W Springer
- Department of Physics and Astronomy, University of Utah, Salt Lake City, UT, USA
| | - O Tibolla
- Universidad Politecnica de Pachuca, Pachuca, Hgo, Mexico
| | - K Tollefson
- Department of Physics and Astronomy, Michigan State University, East Lansing, MI, USA
| | - I Torres
- Instituto Nacional de Astrof'isica, Óptica y Electrónica, Puebla, Mexico
| | - R Torres-Escobedo
- Tsung-Dao Lee Institute & School of Physics and Astronomy, Shanghai Jiao Tong University, Shanghai, People's Republic of China
| | - R Turner
- Department of Physics, Michigan Technological University, Houghton, MI, USA
| | - F Ureña-Mena
- Instituto Nacional de Astrof'isica, Óptica y Electrónica, Puebla, Mexico
| | - E Varela
- Facultad de Ciencias F'isico Matemáticas, Benemérita Universidad Autónoma de Puebla, Puebla, Mexico
| | - L Villaseñor
- Facultad de Ciencias F'isico Matemáticas, Benemérita Universidad Autónoma de Puebla, Puebla, Mexico
| | - X Wang
- Department of Physics, Michigan Technological University, Houghton, MI, USA
| | - I J Watson
- University of Seoul, Seoul, Rep. of Korea
| | - E Willox
- Department of Physics, University of Maryland, College Park, MD, USA
| | - S Yun-Cárcamo
- Department of Physics, University of Maryland, College Park, MD, USA
| | - H Zhou
- Tsung-Dao Lee Institute & School of Physics and Astronomy, Shanghai Jiao Tong University, Shanghai, People's Republic of China
| | - C de León
- Universidad Michoacana de San Nicolás de Hidalgo, Morelia, Mexico
| | - J F Beacom
- Center for Cosmology and AstroParticle Physics (CCAPP), Ohio State University, Columbus, Ohio 43210, USA
- Department of Physics, Ohio State University, Columbus, Ohio 43210, USA
- Department of Astronomy, Ohio State University, Columbus, Ohio 43210, USA
| | - T Linden
- The Oskar Klein Centre, Department of Physics, Stockholm University, AlbaNova, SE-10691 Stockholm, Sweden
| | - K C Y Ng
- Department of Physics, The Chinese University of Hong Kong, Sha Tin, Hong Kong, China
| | - A H G Peter
- Center for Cosmology and AstroParticle Physics (CCAPP), Ohio State University, Columbus, Ohio 43210, USA
- Department of Physics, Ohio State University, Columbus, Ohio 43210, USA
- Department of Astronomy, Ohio State University, Columbus, Ohio 43210, USA
- School of Natural Sciences, Institute for Advanced Study, 1 Einstein Drive, Princeton, NJ 08540, USA
| | - B Zhou
- William H. Miller III Department of Physics and Astronomy, Johns Hopkins University, Baltimore, Maryland 21218, USA
| |
Collapse
|
4
|
Schild CO, Boabaid FM, Olivera LGS, Armendano JI, Saravia A, Custodio A, Algorta J, Alvarez C, Jaurena M, Dixon RM, Riet-Correa F. Response of cows with osteomalacia grazing sub-tropical native pastures to phosphorus supplementation with loose mineral mix or feed blocks. Vet J 2023; 298-299:106013. [PMID: 37355009 DOI: 10.1016/j.tvjl.2023.106013] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/06/2022] [Revised: 06/14/2023] [Accepted: 06/20/2023] [Indexed: 06/26/2023]
Abstract
Osteomalacia outbreaks often occur in cattle grazing native pastures in regions with endemic phosphorous (P) deficiency. This study evaluated the responses of two groups of cows, initially with clinical signs of chronic P deficiency, to P supplements (100 g P/kg) offered ad libitum for 13 weeks as a loose mineral mix (LMM group) or the same mineral mix offered as blocks (BMM group). Half of the cows in each group were categorized as 'with' or 'without' severe osteopenia according to a test that depended on the resistance to penetration of a needle through the left lateral process of the L4-L5 lumbar vertebra. The groups grazed two paddocks that were switched each 3 weeks. The liveweight, supplement intakes, and the P-concentrations in soil, forage, blood, and external cortical bone (ECB) of the ribs were measured. The bicarbonate-extractable P in soil was 3.5 mg/kg. The mean of total P in forage (0.95 g/kg/DM), inorganic P in serum (iP, 0.96 mmol/L), and total P in the ECB of the ribs (85 mg/mL) at the beginning of the experiment were all low and consistent with severe chronic P deficiency. The P supplementation allowed clinical recovery in 18/20 cows with their serum and ECB P and calcium approaching normal values and in the two remaining cows the only sign was abnormal gait. Cows consumed more of the LMM than BMM supplement (means 8.3 and 6.6 g P/day, respectively). After 13 weeks cows initially classified as 'with severe osteopenia' and supplemented with LMM had higher (P < 0.05) final liveweight (difference = 21.6 kg), iP (difference = 0.74 mmol/L), bone Ca (difference = 65.7 mg/mL) and bone P (difference = 26.5 mg/mL) concentrations and lower (P < 0.01) final serum Ca/iP ratio (difference = -0.65) than cows with severe osteopenia but supplemented with BMM. The treatment of severe P deficiency cows grazing P deficient sub-tropical grasslands by P supplementation for 13 weeks was more effective with LMM than BMM.
Collapse
Affiliation(s)
- C O Schild
- Instituto Nacional de Investigación Agropecuaria (INIA), Plataforma de Investigación en Salud Animal (PSA), Estación Experimental (EE) Tacuarembó, Ruta 5, km 386, Tacuarembó 45000, Uruguay; California Animal Health Food Safety, University of California Davis, 105 W Central Ave, San Bernardino, CA 92408, USA
| | - F M Boabaid
- Polo de Desarrollo Universitario, Instituto Superior de la Carne, Sede Tacuarembó, CENUR Noreste, Universidad de la República, Ruta 5, km 386, Tacuarembó 45000, Uruguay
| | - L G S Olivera
- Instituto Nacional de Investigación Agropecuaria (INIA), Plataforma de Investigación en Salud Animal (PSA), Estación Experimental (EE) Tacuarembó, Ruta 5, km 386, Tacuarembó 45000, Uruguay
| | - J I Armendano
- Facultad de Ciencias Veterinarias, Universidad Nacional del Centro de la Provincia de Buenos Aires, Paraje Arroyo Seco S/N, Tandil 7000, Argentina
| | - A Saravia
- INIA, PSA, EE La Estanzuela, Ruta 50 km 11, Colonia 70000, Uruguay
| | - A Custodio
- Instituto Nacional de Investigación Agropecuaria (INIA), Plataforma de Investigación en Salud Animal (PSA), Estación Experimental (EE) Tacuarembó, Ruta 5, km 386, Tacuarembó 45000, Uruguay
| | - J Algorta
- Barraca Deambrosi S.A., Av. Rondeau 2257, Montevideo 11800, Uruguay
| | - C Alvarez
- Laboratorio Analítico Agroindustrial, Ruta 90 km 5, Paysandú 60000, Uruguay
| | - M Jaurena
- INIA, Programa Nacional de Investigación en Pasturas y Forrajes, EE Tacuarembó, Uruguay
| | - R M Dixon
- Queensland Alliance for Agriculture and Food Innovation, The University of Queensland, St Lucia, Queensland 4072, Australia
| | - F Riet-Correa
- Programa de pós-graduação em Ciência Animal nos Trópicos, Escola de Medicina Veterinária e Zootecnia, Universidade Federal da Bahia, Salvador 41405-000, Brazil.
| |
Collapse
|
5
|
Tofe S, Argüelles I, Forteza A, Alvarez C, Repetto A, Masmiquel L, Rodríguez I, Losada E, Sukunza N, Cabrer M, Sifontes M, Del Barrio MDM, Barceló A, Tofé A, Pereg V. Age-standardized incidence, mortality rate and trend changes of thyroid cancer in the Balearic Islands during the 2000-2020 period: a population-based study. Eur Thyroid J 2023; 12:ETJ-22-0183. [PMID: 36913315 PMCID: PMC10160559 DOI: 10.1530/etj-22-0183] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/03/2023] [Accepted: 03/13/2023] [Indexed: 03/14/2023] Open
Abstract
OBJECTIVE Global thyroid cancer (TC) incidence is growing worldwide, but great heterogenicity exists among published studies and thus, population-specific epidemiological studies are needed to adequate health resources and evaluate impact of overdiagnosis. METHODS We conducted a Public Health System database retrospective review of TC incident cases from 2000 to 2020 in the Balearic Islands region and evaluated age-standardized incidence (ASIR), age at diagnosis, gender distribution, tumor size and histological subtype, mortality rate (MR) and cause of death. Estimated annual percent changes (EAPCs) were also evaluated and data from the 2000-2009 period was compared to the 2010-2020, when neck ultrasound (US) was routinely performed by clinicians at Endocrinology Departments. RESULTS A total of 1,387 incident cases of TC were detected. Overall, ASIR (x105) was 5.01 with a 7.82% increment in EAPC. A significant increase in the 2010-2020 period was seen for ASIR (6.99 vs. 2.82, p<0.001) and age at diagnosis (52.11 vs. 47.32, p<0.001) compared to the 2000-2009 period. A reduction in tumor size (2.00 vs 2.78 cm, p<0,001) and a 6.31% increase in Micropapillary TC (p<0.05) were also seen. Disease-specific MR remained stable at 0.21 (x105). Mean age at diagnosis for all mortality groups was older than survivors (p<0.001). CONCLUSION Incidence of TC has grown in the 2000-2020 period in the Balearic Islands, but mortality rate has not changed. Beyond other factors, a significant contribution of overdiagnosis to this increased incidence is likely, due to changes in the routine management of thyroid nodular disease and increased availability of neck US.
Collapse
Affiliation(s)
- Santiago Tofe
- S Tofe, endocrinology, Hospital Universitari Son Espases, Palma de Mallorca, 07120, Spain
| | - Iñaki Argüelles
- I Argüelles, Endocrrinology , Hospital Universitari Son Espases, PALMA DE MALLORCA, 07120, Spain
| | - Ana Forteza
- A Forteza, Pathology, Hospital Universitario Son Espases, Palma, Spain
| | - Cristina Alvarez
- C Alvarez, Endocrine Surgery, Hospital Universitari Son Espases, Palma de Mallorca, Spain
| | - Alessandra Repetto
- A Repetto, Nuclear Medicine, Hospital Universitari Son Espases, Palma de Mallorca, Spain
| | - Luis Masmiquel
- L Masmiquel, endocrinology, Hospital Son Llatzer, Palma de Mallorca, Spain
| | - Irene Rodríguez
- I Rodríguez, endocrinology, Hospital Son Llatzer, Palma de Mallorca, Spain
| | - Eladio Losada
- E Losada, endocrinology, Hospital Can Misses, Eivissa, Spain
| | - Nuria Sukunza
- N Sukunza, endocrinology, Hospital de Manacor, Manacor, Spain
| | - María Cabrer
- M Cabrer, endocrinology, Hospital Comarcal de Inca, Inca, Spain
| | - Mildred Sifontes
- M Sifontes, endocrinology, Hospital General Mateu Orfila, Mahon, Spain
| | | | - Antonia Barceló
- A Barceló, Laboratory, Hospital Universitari Son Espases, Palma de Mallorca, Spain
| | - Alvaro Tofé
- A Tofé, Hospital Universitario Puerta del Mar, Cadiz, Spain
| | - Vicente Pereg
- V Pereg, endocrinology, Hospital Universitari Son Espases, Palma de Mallorca, Spain
| |
Collapse
|
6
|
Rodríguez-Espinosa D, Broseta JJ, Bastida C, Álvarez-Mora MI, Nicolau C, Alvarez C, Agraz-Pamplona I, Sánchez-Baya M, Furlano M, Ruiz C, Quintana LF, Piñeiro GJ, Poch E, Torra-Balcells R, Blasco M. Creatine Kinase Elevation in Autosomal Dominant Polycystic Kidney Disease Patients on Tolvaptan Treatment. Nephron Clin Pract 2022; 147:152-157. [PMID: 36088902 PMCID: PMC10137304 DOI: 10.1159/000526368] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/11/2022] [Accepted: 08/03/2022] [Indexed: 11/19/2022] Open
Abstract
<b><i>Background:</i></b> Autosomal dominant polycystic kidney disease (ADPKD) is the most common hereditary cause of end-stage kidney disease. Currently, tolvaptan is the only treatment that has proven to delay disease progression. The most notable side effect of this therapy is drug-induced liver injury; however, recently, there have been two reports of creatine kinase (CK) elevation in ADPKD patients on tolvaptan treatment. We set out to monitor and determine the actual incidence of CK elevation and evaluate its potential association with other clinical factors. <b><i>Methods:</i></b> This is an observational retrospective multicenter study performed in rapidly progressive ADPKD patients on tolvaptan treatment from Barcelona, Spain. Laboratory tests, demographics, treatment dose, and reported symptoms were collected from October 2018 to March 2021. <b><i>Results:</i></b> Ninety-five patients initiated tolvaptan treatment during follow-up. The medication had to be discontinued in 31 (32.6%) patients, primarily due to aquaretic effects (12.6%), elevated liver enzymes (8.4%), and symptomatic or persistently elevated CK levels (3.2%). Moreover, a total of 27 (28.4%) patients had elevated CK levels, with most of them being either transient (12.6%), mild and asymptomatic (4.2%), or resolved after dose reduction (3.2%) or temporary discontinuation (2.1%). <b><i>Conclusion:</i></b> We present the largest cohort that has monitored CK levels in a real-life setting, finding them elevated in 28.4% of patients. More research and monitoring will help us understand the clinical implications and the pathophysiological mechanism of CK elevation in this population.
Collapse
Affiliation(s)
- Diana Rodríguez-Espinosa
- Nephrology and Kidney Transplantation Department, Centro de Referencia en Enfermedad Glomerular Compleja del Sistema Nacional de Salud (CSUR), Hospital Clínic, University of Barcelona, Barcelona, Spain,
| | - José Jesús Broseta
- Nephrology and Kidney Transplantation Department, Centro de Referencia en Enfermedad Glomerular Compleja del Sistema Nacional de Salud (CSUR), Hospital Clínic, University of Barcelona, Barcelona, Spain
| | - Carla Bastida
- Department of Pharmacy, Hospital Clínic, Barcelona, Spain
| | | | - Carlos Nicolau
- Genito-urinary Department, Diagnostic Imaging Center, Hospital Clínic, Barcelona, Spain
| | - Cristina Alvarez
- Nephrology and Kidney Transplantation Department, Centro de Referencia en Enfermedad Glomerular Compleja del Sistema Nacional de Salud (CSUR), Hospital Clínic, University of Barcelona, Barcelona, Spain
| | | | - Maya Sánchez-Baya
- Department of Nephrology, Fundació Puigvert, IIB Sant Pau, Universitat Autònoma, Barcelona, Spain
| | - Mónica Furlano
- Department of Nephrology, Fundació Puigvert, IIB Sant Pau, Universitat Autònoma, Barcelona, Spain
| | - César Ruiz
- Department of Nephrology, Fundació Puigvert, IIB Sant Pau, Universitat Autònoma, Barcelona, Spain
| | - Luis F Quintana
- Nephrology and Kidney Transplantation Department, Centro de Referencia en Enfermedad Glomerular Compleja del Sistema Nacional de Salud (CSUR), Hospital Clínic, University of Barcelona, Barcelona, Spain
| | - Gastón J Piñeiro
- Nephrology and Kidney Transplantation Department, Centro de Referencia en Enfermedad Glomerular Compleja del Sistema Nacional de Salud (CSUR), Hospital Clínic, University of Barcelona, Barcelona, Spain
| | - Esteban Poch
- Nephrology and Kidney Transplantation Department, Centro de Referencia en Enfermedad Glomerular Compleja del Sistema Nacional de Salud (CSUR), Hospital Clínic, University of Barcelona, Barcelona, Spain
| | - Roser Torra-Balcells
- Department of Nephrology, Fundació Puigvert, IIB Sant Pau, Universitat Autònoma, Barcelona, Spain
| | - Miquel Blasco
- Nephrology and Kidney Transplantation Department, Centro de Referencia en Enfermedad Glomerular Compleja del Sistema Nacional de Salud (CSUR), Hospital Clínic, University of Barcelona, Barcelona, Spain
| |
Collapse
|
7
|
Yarahmadov T, Wang J, Sanchez-Taltavull D, Brodie T, Büchi I, Stroka D, Keogh A, Alvarez C, Beldi G. Primary infection by E. multilocularis induces distinct patterns of hepatic crosstalk between natural killer T and regulatory T cells in mice. Br J Surg 2022. [DOI: 10.1093/bjs/znac176.009] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
Abstract
Abstract
Objective
The larval stage of the helminthic cestode Echinococcus multilocularis can inflict tumor-like hepatic lesions that cause the parasitic disease alveolar echinococcosis (AE) in humans. Recently, opportunistic properties of the disease have been proposed based on the increased incidence in immunocompromised patients as well as on mouse models, indicating that an appropriate adaptive immune response is required for the control of the disease. However, little is known about how the local hepatic immune responses modulate the infection with E. multilocularis.
Methods
In a mouse model of oral infection that mimics the normal infection route in human patients, the adaptive immune response in the liver was assessed using single cell RNA sequencing of isolated hepatic CD3+ T cells at different infection stages.
Results
Single-cell RNA sequencing revealed specific temporal changes of natural killer T (NKT) cells and regulatory T (Treg) cells, indicating that these two cell types expand in the early phase and are subsequently inhibited in the late phase of infection. Receptor-ligand complex analysis via CellPhoneDB, consistently revealed high number of interactions between Tregs and NKT mainly at day 10 post infection. Relevant interactions between NKT and Treg cells at early phases include regulation of cell adhesion molecules such as integrins and selectins and TNF-dependent signalling. Immune suppressing interactions that include the checkpoint inhibitors (PD-1 and PD-L1), purinergic (ENTPD1, ADORA2A) and TGF-beta signalling are down regulated at early time points. String analysis supported these findings.
Conclusion
The data indicate that early interactions between NKT and Tregs potentially promote the formation of hepatic lesions and later also contribute to immunological suppression of the resolution of parasite-induced pathology. The obtained data provide a fresh insight on the adaptive immune responses and local regulatory pathways at different infection stages of E. multilocularis in mice.
Collapse
Affiliation(s)
- T Yarahmadov
- Department for Visceral Surgery and Medicine, Inselspital, Bern University Hospital , Bern, Switzerland
| | - J Wang
- Department for Infectous Diseases, Inselspital, Bern University Hospital , Bern, Switzerland
| | - D Sanchez-Taltavull
- Department for Visceral Surgery and Medicine, Inselspital, Bern University Hospital , Bern, Switzerland
| | - T Brodie
- Department for Visceral Surgery and Medicine, Inselspital, Bern University Hospital , Bern, Switzerland
| | - I Büchi
- Department for Visceral Surgery and Medicine, Inselspital, Bern University Hospital , Bern, Switzerland
| | - D Stroka
- Department for Visceral Surgery and Medicine, Inselspital, Bern University Hospital , Bern, Switzerland
| | - A Keogh
- Department for Visceral Surgery and Medicine, Inselspital, Bern University Hospital , Bern, Switzerland
| | - C Alvarez
- Department for Parasitology, University of Zurich , Zurich, Switzerland
| | - G Beldi
- Department for Visceral Surgery and Medicine, Inselspital, Bern University Hospital , Bern, Switzerland
| |
Collapse
|
8
|
Rivero-Sánchez L, Gavric A, Herrero J, Remedios D, Alvarez V, Albéniz E, Gordillo J, Puig I, López-Vicente J, Huerta A, López-Cerón M, Salces I, Peñas B, Parejo S, Rodriguez E, Herraiz M, Carretero C, Gimeno-Garcia AZ, Saperas E, Alvarez C, Arnau-Collell C, Ortiz O, Sánchez A, Jung G, Balaguer F, Pellisé M. The "diagnose and leave in" strategy for diminutive rectosigmoid polyps in Lynch syndrome: a post hoc analysis from a randomized controlled trial. Endoscopy 2022; 54:27-34. [PMID: 33271604 DOI: 10.1055/a-1328-5405] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/07/2023]
Abstract
BACKGROUND The "diagnose-and-leave-in" policy has been established to reduce the risks and costs related to unnecessary polypectomies in the average-risk population. In individuals with Lynch syndrome, owing to accelerated carcinogenesis, the general recommendation is to remove all polyps, irrespective of size, location, and appearance. We evaluated the feasibility and safety of the diagnose-and-leave-in strategy in individuals with Lynch syndrome. METHODS : We performed a post hoc analysis based on per-polyp data from a randomized, clinical trial conducted by 24 dedicated colonoscopists at 14 academic centers, in which 256 patients with confirmed Lynch syndrome underwent surveillance colonoscopy from July 2016 to January 2018. In vivo optical diagnosis with confidence level for all detected lesions was obtained before polypectomy using virtual chromoendoscopy alone or with dye-based chromoendoscopy. Primary outcome was the negative predictive value (NPV) for neoplasia of high-confidence optical diagnosis among diminutive (≤ 5 mm) rectosigmoid lesions. Histology was the reference standard. RESULTS Of 147 rectosigmoid lesions, 128 were diminutive. In 103 of the 128 lesions (81 %), the optical diagnostic confidence was high and showed an NPV of 96.0 % (95 % confidence interval [CI] 88.9 %-98.6 %) and accuracy of 89.3 % (95 %CI 81.9 %-93.9 %). By following the diagnose-and-leave-in policy, we would have avoided 59 % (75/128) of polypectomies at the expense of two diminutive low grade dysplastic adenomas and one diminutive sessile serrated lesion that would have been left in situ. CONCLUSION In patients with Lynch syndrome, the diagnose-and-leave-in strategy for diminutive rectosigmoid polyps would be feasible and safe.
Collapse
Affiliation(s)
- Liseth Rivero-Sánchez
- Hospital Clinic de Barcelona, Department of Gastroenterology, Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.,Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Barcelona, Spain
| | - Aleksandar Gavric
- Hospital Clinic de Barcelona, Department of Gastroenterology, Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.,University Medical Centre Ljubljana, Department of Gastroenterology and Hepatology Ljubljana, Slovenia
| | - Jesús Herrero
- Complexo Hospitalario Universitario de Ourense, Instituto de Investigación Biomédica Galicia Sur, CIBERehd, Gastroenterology, Ourense, Spain
| | - David Remedios
- Complexo Hospitalario Universitario de Ourense, Instituto de Investigación Biomédica Galicia Sur, CIBERehd, Gastroenterology, Ourense, Spain
| | - Victoria Alvarez
- Complexo Hospitalario de Pontevedra, Digestive Department, Pontevedra, Spain
| | - Eduardo Albéniz
- Complejo Hospitalario de Navarra, Digestive System Service, Endoscopy Unit, Navarrabiomed, Universidad Pública de Navarra, IdiSNa, Pamplona, Spain
| | - Jordi Gordillo
- Hospital de la Santa Creu i Sant Pau, Gastroenterology Unit, Barcelona, Spain
| | - Ignasi Puig
- Althaia, Xarxa Assistencial Universitària de Manresa, Gastroenterology Department, Manresa, Spain
| | - Jorge López-Vicente
- Hospital Universitario de Móstoles, Digestive System Service, Móstoles, Madrid, Spain
| | - Alain Huerta
- Hospital Galdakao-Usansolo, Department of Gastroenterology, Galdakao, Spain
| | - María López-Cerón
- Hospital Universitario 12 de Octubre, Digestive System Service, Madrid, Spain
| | - Inmaculada Salces
- Hospital Universitario 12 de Octubre, Digestive System Service, Madrid, Spain
| | - Beatriz Peñas
- Hospital Universitario Ramon y Cajal, Department of Gastroenterology, Madrid, Spain.,Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Madrid, Spain
| | - Sofía Parejo
- Hospital Universitario Ramon y Cajal, Department of Gastroenterology, Madrid, Spain
| | - Enrique Rodriguez
- Hospital Universitario Ramon y Cajal, Department of Gastroenterology, Madrid, Spain.,Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Madrid, Spain
| | - Maite Herraiz
- University of Navarra Clinic-IdiSNA, Gastroenterology Department, Pamplona, Spain
| | - Cristina Carretero
- University of Navarra Clinic-IdiSNA, Gastroenterology Department, Pamplona, Spain
| | - Antonio Z Gimeno-Garcia
- Hospital Universitario de Canarias, Gastroenterology Department, Santa Cruz de Tenerife, Spain
| | - Esteban Saperas
- Hospital General de Catalunya, Gastroenterology Department, Sant Cugat del Vallès, Spain
| | | | - Coral Arnau-Collell
- Hospital Clinic de Barcelona, Department of Gastroenterology, Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS), Barcelona, Spain
| | - Oswaldo Ortiz
- Hospital Clinic de Barcelona, Department of Gastroenterology, Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.,Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Barcelona, Spain
| | - Ariadna Sánchez
- Hospital Clinic de Barcelona, Department of Gastroenterology, Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.,Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Barcelona, Spain
| | - Gerhard Jung
- Hospital Clinic de Barcelona, Department of Gastroenterology, Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.,Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Barcelona, Spain
| | - Francesc Balaguer
- Hospital Clinic de Barcelona, Department of Gastroenterology, Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.,Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Barcelona, Spain
| | - María Pellisé
- Hospital Clinic de Barcelona, Department of Gastroenterology, Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.,Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Barcelona, Spain
| |
Collapse
|
9
|
Amich I, Anguita E, Escribano-Serrat S, Alvarez C, Rodríguez-Muñoz D, García V, Bello R, Peña-Pedrosa JA, Martínez-Micaelo N, Amigó N, Ortiz P, Torrejón MJ, Boscá L, Martín-Sánchez J, Aranda A, Alemany S. Free triiodothyronine levels and age influences the metabolic profile and COVID-19 severity parameters in euthyroid and levothyroxine-treated patients. Front Endocrinol (Lausanne) 2022; 13:1025032. [PMID: 36440226 PMCID: PMC9682171 DOI: 10.3389/fendo.2022.1025032] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/22/2022] [Accepted: 10/06/2022] [Indexed: 11/11/2022] Open
Abstract
Metabolic reprogramming is required to fight infections and thyroid hormones are key regulators of metabolism. We have analyzed in hospitalized COVID-19 patients: 40 euthyroid and 39 levothyroxine (LT4)-treated patients in the ward and 29 euthyroid and 9 LT4-treated patients in the intensive care unit (ICU), the baseline characteristics, laboratory data, thyroid-stimulating hormone (TSH), free thyroxine (FT4), free triiodothyronine (FT3), the FT3/FT4 ratio, 11 antiviral cytokines and 74 metabolomic parameters. No evidence for significant differences between euthyroid and LT4-treated patients were found in the biochemical, metabolomic and cytokines parameters analyzed. Only TSH (p=0.009) and ferritin (p=0.031) showed significant differences between euthyroid and LT4-treated patients in the ward, and TSH (p=0.044) and FT4 (p=0.012) in the ICU. Accordingly, severity and mortality were similar in euthyroid and LT4-treated patients. On the other hand, FT3 was negatively related to age (p=0.012), independently of sex and body mass index in hospitalized COVID-19 patients. Patients with low FT3 and older age showed a worse prognosis and higher levels of the COVID-19 severity markers IL-6 and IL-10 than patients with high FT3. IL-6 negatively correlated with FT3 (p=0.023) independently of age, body mass index and sex, whereas IL-10 positively associated with age (p=0.035) independently of FT3, body mass index and sex. A metabolomic cluster of 6 parameters defined low FT3 ward patients. Two parameters, esterified cholesterol (p=4.1x10-4) and small HDL particles (p=6.0x10-5) correlated with FT3 independently of age, body mass index and sex, whereas 3-hydroxybutyrate (p=0.010), acetone (p=0.076), creatinine (p=0.017) and high-density-lipoprotein (HDL) diameter (p=8.3x10-3) were associated to FT3 and also to age, with p-values of 0.030, 0.026, 0.017 and 8.3x10-3, respectively. In conclusion, no significant differences in FT3, cytokines, and metabolomic profile, or in severity and outcome of COVID-19, were found during hospitalization between euthyroid patients and hypothyroid patients treated with LT4. In addition, FT3 and age negatively correlate in COVID-19 patients and parameters that predict poor prognosis were associated with low FT3, and/or with age. A metabolomic cluster indicative of a high ketogenic profile defines non-critical hospitalized patients with low FT3 levels.
Collapse
Affiliation(s)
- Inés Amich
- Department of Emergency, Hospital Príncipe de Asturias, Alcalá de Henares, Madrid, Spain
| | - Eduardo Anguita
- Department of Hematology, Hospital Clínico San Carlos, Instituto de Medicina de Laboratorio (IML), Instituto de Investigación Sanitaria San Carlos (IdISSC), Madrid, Spain
- Department of Medicine, Universidad Complutense de Madrid (UCM), Madrid, Spain
| | - Silvia Escribano-Serrat
- Department of Hematology, Hospital Clínico San Carlos, Instituto de Medicina de Laboratorio (IML), Instituto de Investigación Sanitaria San Carlos (IdISSC), Madrid, Spain
| | - Cristina Alvarez
- Clinical Analysis Laboratory, IML, IdISSC, Hospital Clínico San Carlos, Madrid, Spain
| | - Diego Rodríguez-Muñoz
- Department of Metabolism and Cell Signaling, Instituto de Investigaciones Biomédicas “Alberto Sols”, CSIC-UAM, Madrid, Spain
| | - Verónica García
- Hospital Pharmacy, IdISSC, Hospital Clínico San Carlos, Madrid, Spain
| | - Rocío Bello
- Hospital Pharmacy, IdISSC, Hospital Clínico San Carlos, Madrid, Spain
| | | | - Neus Martínez-Micaelo
- Biosfer Teslab, Department of Basic Medical Sciences, Institut d'Investigació Sanitària Pere Virgili (IISPV), Reus, Spain
| | - Nuria Amigó
- Biosfer Teslab, Department of Basic Medical Sciences, Institut d'Investigació Sanitària Pere Virgili (IISPV), Reus, Spain
- Centro de Investigación Biomédicas en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III (ISCIII), Madrid, Spain
| | - Pablo Ortiz
- Department of Metabolism and Cell Signaling, Instituto de Investigaciones Biomédicas “Alberto Sols”, CSIC-UAM, Madrid, Spain
| | - María José Torrejón
- Clinical Analysis Laboratory, IML, IdISSC, Hospital Clínico San Carlos, Madrid, Spain
| | - Lisardo Boscá
- Department of Metabolism and Cell Signaling, Instituto de Investigaciones Biomédicas “Alberto Sols”, CSIC-UAM, Madrid, Spain
- Centro de Investigación Biomédicas en enfermedades Cardiovasculares (CIBERCV), Instituto de Salud Carlos III (ISCIII), Madrid, Spain
| | - Javier Martín-Sánchez
- Department of Medicine, Universidad Complutense de Madrid (UCM), Madrid, Spain
- Department of Emergency, IdISSC, Hospital Clínico San Carlos, Madrid, Spain
| | - Ana Aranda
- Department of Endocrine and Nervous System Pathophysiology, Instituto de Investigaciones Biomédicas “Alberto Sols”, CSIC-UAM, Centro de Investigación Biomédicas en Red de Cáncer (CIBERONC), Madrid, Spain
- Centro de Investigación Biomédicas de Cáncer (CIBERONC), Instituto de Salud Carlos III (ISCIII), Madrid, Spain
- *Correspondence: Ana Aranda, ; Susana Alemany,
| | - Susana Alemany
- Department of Metabolism and Cell Signaling, Instituto de Investigaciones Biomédicas “Alberto Sols”, CSIC-UAM, Madrid, Spain
- *Correspondence: Ana Aranda, ; Susana Alemany,
| |
Collapse
|
10
|
Del Valle A, Acosta-Rivero N, Laborde RJ, Cruz-Leal Y, Cabezas S, Luzardo MC, Alvarez C, Labrada M, Rodríguez A, Rodríguez GL, Raymond J, Nogueira CV, Grubaugh D, Fernández LE, Higgins D, Lanio ME. Sticholysin II shows similar immunostimulatory properties to LLO stimulating dendritic cells and MHC-I restricted T cell responses of heterologous antigen. Toxicon 2021; 200:38-47. [PMID: 34237340 DOI: 10.1016/j.toxicon.2021.06.020] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/21/2020] [Revised: 06/22/2021] [Accepted: 06/30/2021] [Indexed: 10/20/2022]
Abstract
Induction of CD8+ T cell responses against tumor cells and intracellular pathogens is an important goal of modern vaccinology. One approach of translational interest is the use of liposomes encapsulating pore-forming proteins (PFPs), such as Listeriolysin O (LLO), which has shown efficacy at priming strong and sustained CD8+ T cell responses. Recently, we have demonstrated that Sticholysin II (StII), a PFP from the sea anemone Stichodactyla helianthus, co-encapsulated into liposomes with ovalbumin (OVA) was able to stimulate, antigen presenting cells, antigen-specific CD8+ T cells and anti-tumor activity in mice. In the present study, we aimed to compare StII and LLO in terms of their abilities to stimulate dendritic cells and to induce major histocompatibility complex (MHC) class I restricted T cell responses against OVA. Interestingly, StII exhibited similar abilities to LLO in vitro of inducing dendritic cells maturation, as measured by increased expression of CD40, CD80, CD86 and MHC-class II molecules, and of stimulating OVA cross-presentation to a CD8+ T cell line. Remarkably, using an ex vivo Enzyme-Linked ImmunoSpot Assay (ELISPOT) to monitor gamma interferon (INF-γ) producing effector memory CD8+ T cells, liposomal formulations containing either StII or LLO induced comparable frequencies of OVA-specific INF-γ producing CD8+ T cells in mice that were sustained in time. However, StII-containing liposomes stimulated antigen-specific memory CD8+ T cells with a higher potential to secrete IFN-γ than liposomes encapsulating LLO. This StII immunostimulatory property further supports its use for the rational design of T cell vaccines against cancers and intracellular pathogens. In summary, this study indicates that StII has immunostimulatory properties similar to LLO, despite being evolutionarily distant PFPs.
Collapse
Affiliation(s)
- A Del Valle
- Center for Protein Studies, Faculty of Biology, Havana University (UH) and Lab UH-CIM, Cuba
| | - N Acosta-Rivero
- Center for Protein Studies, Faculty of Biology, Havana University (UH) and Lab UH-CIM, Cuba.
| | - R J Laborde
- Center for Protein Studies, Faculty of Biology, Havana University (UH) and Lab UH-CIM, Cuba
| | - Y Cruz-Leal
- Center for Protein Studies, Faculty of Biology, Havana University (UH) and Lab UH-CIM, Cuba
| | - S Cabezas
- Center for Protein Studies, Faculty of Biology, Havana University (UH) and Lab UH-CIM, Cuba
| | - M C Luzardo
- Center for Protein Studies, Faculty of Biology, Havana University (UH) and Lab UH-CIM, Cuba
| | - C Alvarez
- Center for Protein Studies, Faculty of Biology, Havana University (UH) and Lab UH-CIM, Cuba
| | - M Labrada
- Center of Molecular Immunology (CIM), Playa, La Habana, Cuba
| | - A Rodríguez
- Center of Molecular Immunology (CIM), Playa, La Habana, Cuba
| | - G L Rodríguez
- Center of Molecular Immunology (CIM), Playa, La Habana, Cuba
| | - J Raymond
- Center of Molecular Immunology (CIM), Playa, La Habana, Cuba
| | | | - D Grubaugh
- Harvard Medical School, Harvard University, USA
| | - L E Fernández
- Center of Molecular Immunology (CIM), Playa, La Habana, Cuba
| | - D Higgins
- Harvard Medical School, Harvard University, USA
| | - M E Lanio
- Center for Protein Studies, Faculty of Biology, Havana University (UH) and Lab UH-CIM, Cuba.
| |
Collapse
|
11
|
Fabra D, Matesanz AI, Herrero JM, Alvarez C, Balsa LM, Leon IE, Quiroga AG. Two Different Thiosemicarbazone Tauto‐Conformers Coordinate to Palladium (II). Stability and Biological Studies of the Final Complexes. Eur J Inorg Chem 2021. [DOI: 10.1002/ejic.202001066] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022]
Affiliation(s)
- David Fabra
- Inorganic Chemistry Department Universidad Autónoma de Madrid Madrid 28049 Spain
| | - Ana I. Matesanz
- Inorganic Chemistry Department Universidad Autónoma de Madrid Madrid 28049 Spain
| | - Jorge M. Herrero
- Inorganic Chemistry Department Universidad Autónoma de Madrid Madrid 28049 Spain
| | - Cristina Alvarez
- Inorganic Chemistry Department Universidad Autónoma de Madrid Madrid 28049 Spain
| | - Lucia M. Balsa
- Centro de Química Inorgánica (CEQUINOR CONICET-UNLP) Facultad de Ciencias Exactas Universidad Nacional de La Plata Bv 120 1465 1900 La Plata Argentina
| | - Ignacio E. Leon
- Centro de Química Inorgánica (CEQUINOR CONICET-UNLP) Facultad de Ciencias Exactas Universidad Nacional de La Plata Bv 120 1465 1900 La Plata Argentina
| | - Adoracion G. Quiroga
- Inorganic Chemistry Department Universidad Autónoma de Madrid Madrid 28049 Spain
- Institute for Advanced Research in Chemical Sciences (IAdChem) Universidad Autónoma de Madrid Madrid 28049 Spain
| |
Collapse
|
12
|
Araujo PI, Piñeiro-Guerra JM, Yahdjian L, Acreche MM, Alvarez C, Alvarez CR, Costantini A, Chalco Vera J, De Tellería J, Della Chiesa T, Lewczuk NA, Petrasek M, Piccinetti C, Picone L, Portela SI, Posse G, Seijo M, Videla C, Piñeiro G. Drivers of N2O Emissions from Natural Forests and Grasslands Differ in Space and Time. Ecosystems 2020. [DOI: 10.1007/s10021-020-00522-7] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/05/2023]
|
13
|
Albert A, Alfaro R, Alvarez C, Angeles Camacho JR, Arteaga-Velázquez JC, Arunbabu KP, Avila Rojas D, Ayala Solares HA, Baghmanyan V, Belmont-Moreno E, BenZvi SY, Brisbois C, Caballero-Mora KS, Capistrán T, Carramiñana A, Casanova S, Cotti U, Cotzomi J, Coutiño de León S, De la Fuente E, de León C, Dingus BL, DuVernois MA, Díaz-Vélez JC, Ellsworth RW, Engel K, Espinoza C, Fleischhack H, Fraija N, Galván-Gámez A, Garcia D, García-González JA, Garfias F, González MM, Goodman JA, Harding JP, Hernandez S, Hona B, Huang D, Hueyotl-Zahuantitla F, Hüntemeyer P, Iriarte A, Joshi V, Lara A, Lee WH, León Vargas H, Linnemann JT, Longinotti AL, Luis-Raya G, Lundeen J, López-Coto R, Malone K, Marinelli SS, Martinez-Castellanos I, Martínez-Castro J, Martínez-Huerta H, Matthews JA, Miranda-Romagnoli P, Morales-Soto JA, Moreno E, Nayerhoda A, Nellen L, Newbold M, Nisa MU, Noriega-Papaqui R, Omodei N, Peisker A, Pérez-Pérez EG, Rho CD, Rivière C, Rosa-González D, Rosenberg M, Ruiz-Velasco E, Salazar H, Salesa Greus F, Sandoval A, Schneider M, Schoorlemmer H, Sinnis G, Smith AJ, Springer RW, Surajbali P, Tabachnick E, Tanner M, Tibolla O, Tollefson K, Torres I, Torres-Escobedo R, Weisgarber T, Yodh G, Zepeda A, Zhou H. Constraints on Lorentz Invariance Violation from HAWC Observations of Gamma Rays above 100 TeV. Phys Rev Lett 2020; 124:131101. [PMID: 32302173 DOI: 10.1103/physrevlett.124.131101] [Citation(s) in RCA: 9] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/18/2019] [Revised: 02/07/2020] [Accepted: 03/04/2020] [Indexed: 06/11/2023]
Abstract
Because of the high energies and long distances to the sources, astrophysical observations provide a unique opportunity to test possible signatures of Lorentz invariance violation (LIV). Superluminal LIV enables the decay of photons at high energy. The high altitude water Cherenkov (HAWC) observatory is among the most sensitive gamma-ray instruments currently operating above 10 TeV. HAWC finds evidence of 100 TeV photon emission from at least four astrophysical sources. These observations exclude, for the strongest of the limits set, the LIV energy scale to 2.2×10^{31} eV, over 1800 times the Planck energy and an improvement of 1 to 2 orders of magnitude over previous limits.
Collapse
Affiliation(s)
- A Albert
- Physics Division, Los Alamos National Laboratory, Los Alamos, New Mexico 87545, USA
| | - R Alfaro
- Instituto de Física, Universidad Nacional Autónoma de México, Ciudad de Mexico 04510, Mexico
| | - C Alvarez
- Universidad Autónoma de Chiapas, Tuxtla Gutiérrez, Chiapas 29050, Mexico
| | - J R Angeles Camacho
- Instituto de Física, Universidad Nacional Autónoma de México, Ciudad de Mexico 04510, Mexico
| | | | - K P Arunbabu
- Instituto de Geofísica, Universidad Nacional Autónoma de México, Ciudad de Mexico 04510, Mexico
| | - D Avila Rojas
- Instituto de Física, Universidad Nacional Autónoma de México, Ciudad de Mexico 04510, Mexico
| | - H A Ayala Solares
- Department of Physics, Pennsylvania State University, University Park, Pennsylvania 16802, USA
| | - V Baghmanyan
- Institute of Nuclear Physics Polish Academy of Sciences, PL-31342 IFJ-PAN, Krakow 31342, Poland
| | - E Belmont-Moreno
- Instituto de Física, Universidad Nacional Autónoma de México, Ciudad de Mexico 04510, Mexico
| | - S Y BenZvi
- Department of Physics & Astronomy, University of Rochester, Rochester, New York 14627, USA
| | - C Brisbois
- Department of Physics, Michigan Technological University, Houghton, Michigan 49931-1295, USA
| | - K S Caballero-Mora
- Universidad Autónoma de Chiapas, Tuxtla Gutiérrez, Chiapas 29050, Mexico
| | - T Capistrán
- Instituto Nacional de Astrofísica, Óptica y Electrónica, Puebla 72840, Mexico
| | - A Carramiñana
- Instituto Nacional de Astrofísica, Óptica y Electrónica, Puebla 72840, Mexico
| | - S Casanova
- Institute of Nuclear Physics Polish Academy of Sciences, PL-31342 IFJ-PAN, Krakow 31342, Poland
| | - U Cotti
- Universidad Michoacana de San Nicolás de Hidalgo, Morelia 58040, Mexico
| | - J Cotzomi
- Facultad de Ciencias Físico Matemáticas, Benemérita Universidad Autónoma de Puebla, Puebla 72570, Mexico
| | - S Coutiño de León
- Instituto Nacional de Astrofísica, Óptica y Electrónica, Puebla 72840, Mexico
| | - E De la Fuente
- Departamento de Física, CUCEI, Universidad de Guadalajara, Guadalajara 44430, Mexico
| | - C de León
- Universidad Michoacana de San Nicolás de Hidalgo, Morelia 58040, Mexico
| | - B L Dingus
- Physics Division, Los Alamos National Laboratory, Los Alamos, New Mexico 87545, USA
| | - M A DuVernois
- Department of Physics, University of Wisconsin-Madison, Madison, Wisconsin 53706, USA
| | - J C Díaz-Vélez
- Departamento de Física, Centro Universitario de los Valles, Universidad de Guadalajara, Guadalajara 46600, Mexico
| | - R W Ellsworth
- Department of Physics, University of Maryland, College Park, Maryland 20742-4111, USA
| | - K Engel
- Department of Physics, University of Maryland, College Park, Maryland 20742-4111, USA
| | - C Espinoza
- Instituto de Física, Universidad Nacional Autónoma de México, Ciudad de Mexico 04510, Mexico
| | - H Fleischhack
- Department of Physics, Michigan Technological University, Houghton, Michigan 49931-1295, USA
| | - N Fraija
- Instituto de Astronomía, Universidad Nacional Autónoma de México, Ciudad de Mexico 04510, Mexico
| | - A Galván-Gámez
- Instituto de Astronomía, Universidad Nacional Autónoma de México, Ciudad de Mexico 04510, Mexico
| | - D Garcia
- Instituto de Física, Universidad Nacional Autónoma de México, Ciudad de Mexico 04510, Mexico
| | - J A García-González
- Instituto de Física, Universidad Nacional Autónoma de México, Ciudad de Mexico 04510, Mexico
| | - F Garfias
- Instituto de Astronomía, Universidad Nacional Autónoma de México, Ciudad de Mexico 04510, Mexico
| | - M M González
- Instituto de Astronomía, Universidad Nacional Autónoma de México, Ciudad de Mexico 04510, Mexico
| | - J A Goodman
- Department of Physics, University of Maryland, College Park, Maryland 20742-4111, USA
| | - J P Harding
- Physics Division, Los Alamos National Laboratory, Los Alamos, New Mexico 87545, USA
| | - S Hernandez
- Instituto de Física, Universidad Nacional Autónoma de México, Ciudad de Mexico 04510, Mexico
| | - B Hona
- Department of Physics, Michigan Technological University, Houghton, Michigan 49931-1295, USA
| | - D Huang
- Department of Physics, Michigan Technological University, Houghton, Michigan 49931-1295, USA
| | | | - P Hüntemeyer
- Department of Physics, Michigan Technological University, Houghton, Michigan 49931-1295, USA
| | - A Iriarte
- Instituto de Astronomía, Universidad Nacional Autónoma de México, Ciudad de Mexico 04510, Mexico
| | - V Joshi
- Erlangen Centre for Astroparticle Physics, Friedrich-Alexander-Universität Erlangen-Nürnberg, 91058 Erlangen, Germany
| | - A Lara
- Instituto de Geofísica, Universidad Nacional Autónoma de México, Ciudad de Mexico 04510, Mexico
| | - W H Lee
- Instituto de Astronomía, Universidad Nacional Autónoma de México, Ciudad de Mexico 04510, Mexico
| | - H León Vargas
- Instituto de Física, Universidad Nacional Autónoma de México, Ciudad de Mexico 04510, Mexico
| | - J T Linnemann
- Department of Physics and Astronomy, Michigan State University, East Lansing, Michigan 48824, USA
| | - A L Longinotti
- Instituto Nacional de Astrofísica, Óptica y Electrónica, Puebla 72840, Mexico
| | - G Luis-Raya
- Universidad Politecnica de Pachuca, Pachuca, Hgo 42083, Mexico
| | - J Lundeen
- Department of Physics and Astronomy, Michigan State University, East Lansing, Michigan 48824, USA
| | - R López-Coto
- INFN and Universita di Padova, via Marzolo 8, I-35131, Padova, Italy
| | - K Malone
- Physics Division, Los Alamos National Laboratory, Los Alamos, New Mexico 87545, USA
| | - S S Marinelli
- Department of Physics and Astronomy, Michigan State University, East Lansing, Michigan 48824, USA
| | | | - J Martínez-Castro
- Centro de Investigación en Computación, Instituto Politécnico Nacional, México City 07738, Mexico
| | - H Martínez-Huerta
- Instituto de Física de São Carlos, Universidade de São Paulo, São Carlos, Sao Paolo 13566-590, Brasil
| | - J A Matthews
- Dept of Physics and Astronomy, University of New Mexico, Albuquerque, New Mexico 87131, USA
| | | | - J A Morales-Soto
- Universidad Michoacana de San Nicolás de Hidalgo, Morelia 58040, Mexico
| | - E Moreno
- Facultad de Ciencias Físico Matemáticas, Benemérita Universidad Autónoma de Puebla, Puebla 72570, Mexico
| | - A Nayerhoda
- Institute of Nuclear Physics Polish Academy of Sciences, PL-31342 IFJ-PAN, Krakow 31342, Poland
| | - L Nellen
- Instituto de Ciencias Nucleares, Universidad Nacional Autónoma de Mexico, Ciudad de Mexico 04510, Mexico
| | - M Newbold
- Department of Physics and Astronomy, University of Utah, Salt Lake City, Utah 84112, USA
| | - M U Nisa
- Department of Physics and Astronomy, Michigan State University, East Lansing, Michigan 48824, USA
| | | | - N Omodei
- Stanford University, Stanford, California 94305, USA
| | - A Peisker
- Department of Physics and Astronomy, Michigan State University, East Lansing, Michigan 48824, USA
| | - E G Pérez-Pérez
- Universidad Politecnica de Pachuca, Pachuca, Hgo 42083, Mexico
| | - C D Rho
- Department of Physics & Astronomy, University of Rochester, Rochester, New York 14627, USA
| | - C Rivière
- Department of Physics, University of Maryland, College Park, Maryland 20742-4111, USA
| | - D Rosa-González
- Instituto Nacional de Astrofísica, Óptica y Electrónica, Puebla 72840, Mexico
| | - M Rosenberg
- Department of Physics, Pennsylvania State University, University Park, Pennsylvania 16802, USA
| | - E Ruiz-Velasco
- Max-Planck Institute for Nuclear Physics, 69117 Heidelberg, Germany
| | - H Salazar
- Facultad de Ciencias Físico Matemáticas, Benemérita Universidad Autónoma de Puebla, Puebla 72570, Mexico
| | - F Salesa Greus
- Institute of Nuclear Physics Polish Academy of Sciences, PL-31342 IFJ-PAN, Krakow 31342, Poland
| | - A Sandoval
- Instituto de Física, Universidad Nacional Autónoma de México, Ciudad de Mexico 04510, Mexico
| | - M Schneider
- Department of Physics, University of Maryland, College Park, Maryland 20742-4111, USA
| | - H Schoorlemmer
- Max-Planck Institute for Nuclear Physics, 69117 Heidelberg, Germany
| | - G Sinnis
- Physics Division, Los Alamos National Laboratory, Los Alamos, New Mexico 87545, USA
| | - A J Smith
- Department of Physics, University of Maryland, College Park, Maryland 20742-4111, USA
| | - R W Springer
- Department of Physics and Astronomy, University of Utah, Salt Lake City, Utah 84112, USA
| | - P Surajbali
- Max-Planck Institute for Nuclear Physics, 69117 Heidelberg, Germany
| | - E Tabachnick
- Department of Physics, University of Maryland, College Park, Maryland 20742-4111, USA
| | - M Tanner
- Department of Physics, Pennsylvania State University, University Park, Pennsylvania 16802, USA
| | - O Tibolla
- Universidad Politecnica de Pachuca, Pachuca, Hgo 42083, Mexico
| | - K Tollefson
- Department of Physics and Astronomy, Michigan State University, East Lansing, Michigan 48824, USA
| | - I Torres
- Instituto Nacional de Astrofísica, Óptica y Electrónica, Puebla 72840, Mexico
| | - R Torres-Escobedo
- Departamento de Física, CUCEI, Universidad de Guadalajara, Guadalajara 44430, Mexico
- Department of Physics and Astronomy, Texas Tech University, Lubbock, Texas 79409-1051, USA
| | - T Weisgarber
- Department of Physics, University of Wisconsin-Madison, Madison, Wisconsin 53706, USA
| | - G Yodh
- Department of Physics and Astronomy, University of California, Irvine, Irvine, California 92697, USA
| | - A Zepeda
- Physics Department, Centro de Investigacion y de Estudios Avanzados del IPN, Mexico City 07360, Mexico
| | - H Zhou
- Physics Division, Los Alamos National Laboratory, Los Alamos, New Mexico 87545, USA
| |
Collapse
|
14
|
Tam E, Mustehsan M, Haroun M, Farooq M, Alvarez C, Saha S, Forest S, Jakobleff W, Patel S, Sims D, Shin J, Murthy S, Chavez P, Vukelic S, Goldstein D, Jorde U, Saeed O. Outcomes with Temporary Mechanical Circulatory Support Devices during Acute Myocardial Infarction Cardiogenic Shock. J Heart Lung Transplant 2020. [DOI: 10.1016/j.healun.2020.01.951] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022] Open
|
15
|
Snyder EA, Alvarez C, Golightly YM, Renner JB, Jordan JM, Nelson AE. Incidence and progression of hand osteoarthritis in a large community-based cohort: the Johnston County Osteoarthritis Project. Osteoarthritis Cartilage 2020; 28:446-452. [PMID: 32084589 PMCID: PMC7108963 DOI: 10.1016/j.joca.2020.02.028] [Citation(s) in RCA: 17] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/24/2019] [Revised: 12/23/2019] [Accepted: 02/03/2020] [Indexed: 02/02/2023]
Abstract
OBJECTIVE To describe the incidence and progression of radiographic and symptomatic hand osteoarthritis (rHOA and sxHOA) in a large community-based cohort. DESIGN Data were from the Johnston County OA Project (1999-2015, 12 ± 1.2 years follow-up, age 45+). Participants had bilateral hand radiographs each visit, read for Kellgren-Lawrence grade (KLG) at 30 joints. We defined rHOA as KLG ≥2 in ≥1 joint. SxHOA was defined in a hand/joint with rHOA and self-reported symptoms or tenderness on exam. Incidence was assessed in those without, while progression was assessed in those with, baseline rHOA. Proportions or medians are reported; differences by sex and race were assessed using models appropriate for dichotomous or continuous definitions, additionally adjusted for age, education, body mass index (BMI), and weight change. RESULTS Of 800 participants (68% women, 32% African American, mean age 60 years), 327 had baseline rHOA and were older, more often white and female, than those without rHOA (n = 473). The incidence of HOA was high, for rHOA (60%) and for sxHOA (13%). Women were more likely than men to have incident HOA, particularly for distal interphalangeal joint radiographic osteoarthritis (DIP rOA) (adjusted odds ratios (aOR) 1.60 95% confidence intervals (95% CI) [1.03, 2.49]) and sxHOA (aOR 2.98 [1.50, 5.91]). Progressive HOA was more similar by sex, although thumb base rOA progressed more frequently in women than in men (aOR 2.56 [1.44, 4.55]). Particularly HOA incidence, but also progression, was more frequent among whites compared with African Americans. CONCLUSION This study provides much needed information about the natural history of HOA, a common and frequently debilitating condition, in the general population.
Collapse
Affiliation(s)
- E A Snyder
- Thurston Arthritis Research Center, University of North Carolina at Chapel Hill, USA; Department of Medicine, University of North Carolina at Chapel Hill, USA.
| | - C Alvarez
- Thurston Arthritis Research Center, University of North Carolina at Chapel Hill, USA.
| | - Y M Golightly
- Thurston Arthritis Research Center, University of North Carolina at Chapel Hill, USA; Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, USA.
| | - J B Renner
- Thurston Arthritis Research Center, University of North Carolina at Chapel Hill, USA; Department of Radiology, University of North Carolina at Chapel Hill, USA.
| | - J M Jordan
- Thurston Arthritis Research Center, University of North Carolina at Chapel Hill, USA; Department of Medicine, University of North Carolina at Chapel Hill, USA; Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, USA.
| | - A E Nelson
- Thurston Arthritis Research Center, University of North Carolina at Chapel Hill, USA; Department of Medicine, University of North Carolina at Chapel Hill, USA.
| |
Collapse
|
16
|
Vukelic S, Sibinga N, Vlismas P, Alvarez C, Sims D, Saeed O, Shin J, Forest S, Patel S, Goldstein D, Jorde U. Digoxin Treatment Reverses Angiogenic Switch during HeartMate 3 Support and is Associated with Decrease Risk for Gastrointestinal Bleeding. J Heart Lung Transplant 2020. [DOI: 10.1016/j.healun.2020.01.1168] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022] Open
|
17
|
Vignolo Ballesteros JC, Alegretti M, Vacarezza M, Alvarez C, Retamoso E. Estudio de 130 años de defunciones por Suicidio en el Uruguay.1887- 2017. Rev Salud Publica (Bogota) 2019. [DOI: 10.31052/1853.1180.v23.n3.24034] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022] Open
Abstract
El suicidio es una de las expresiones de violencia autoinfligidas, que causa un gran impacto y daño en la familia, en la comunidad y en la sociedad. A nivel mundial se suicidan aproximadamente 800 mil personas por año y Uruguay es uno de los países con tasas de suicidio más elevadas. El objetivo de este estudio es determinar la tendencia de las muertes por suicidio en el Uruguay en el período comprendido entre 1887 y 2017. Se trata de un estudio de tipo descriptivo, del total de personas fallecidas por suicidio en el Uruguay, en el período de estudio. Para el análisis de tendencias se utilizó un modelo de regresión joinpoint, también se calcularon medias móviles y tendencia polinómica. Se observa que en estos 130 años, permanece un aumento significativo de la tasa (p< 0,05). Siendo el sexo masculino quien continúa presentando los valores más altos, conservando el aumento significativo de la tasa (p<0.05) durante todo el período. Uruguay continúa presentando una tasa estandarizada ubicada en el primer tercio de Países con las tasas más altas del mundo y de América. Se recomienda analizar, profundizar y realizar el permanente seguimiento del Plan Nacional de Prevención de Suicidio aprobado por la Autoridad Sanitaria.
Collapse
|
18
|
Osanto S, Alvarez C, Bloem H, van der Hulle T, Jonker M, Ozdemir M, Goossens K, Wijffelman M, Pelger R, Van Poppel H, Burggraaf K. Efficacy of enzalutamide in hormone-sensitive metastatic prostate cancer: Clinical utility of 18F-choline PET and whole body MRI. Ann Oncol 2019. [DOI: 10.1093/annonc/mdz248.043] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
19
|
Farooqi A, Dharmiah S, Alvarez C, Yang J, Sharin V, Danussi C, Irwin D, Ezhilarasan R, Sulman E, Huse J. ATRX Mutant Glioblastoma Stem Cell (GSC) Lines with the Alternative Lengthening of Telomeres Phenotype Display Sensitivity to G-Quadruplex Stabilization. Int J Radiat Oncol Biol Phys 2019. [DOI: 10.1016/j.ijrobp.2019.06.2286] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
20
|
Skliarova H, Cisternino S, Cicoria G, Marengo M, Carturan S, Martini P, Boschi A, Alvarez C, Palmieri V, Esposito J. TECHN-OSP: Molybdenum target preparation techniques for cyclotron-based technetium-99m production. Nucl Med Biol 2019. [DOI: 10.1016/s0969-8051(19)30213-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
21
|
Herrera AM, Brand P, Cavada G, Koppmann A, Rivas M, Mackenney J, Sepúlveda H, Wevar ME, Cruzat L, Soto S, Pérez MA, León A, Contreras I, Alvarez C, Walker B, Flores C, Lezana V, Garrido C, Herrera ME, Rojas A, Andrades C, Chala E, Martínez RA, Vega M, Perillán JA, Seguel H, Przybyzsweski I. Treatment, outcomes and costs of asthma exacerbations in Chilean children: a prospective multicenter observational study. Allergol Immunopathol (Madr) 2019; 47:282-288. [PMID: 30595390 PMCID: PMC7125869 DOI: 10.1016/j.aller.2018.10.003] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/12/2018] [Revised: 10/02/2018] [Accepted: 10/08/2018] [Indexed: 11/21/2022]
Abstract
OBJECTIVE To describe potential regional variations in therapies for severe asthma exacerbations in Chilean children and estimate the associated health expenditures. METHODS Observational prospective cohort study in 14 hospitals over a one-year period. Children five years of age or older were eligible for inclusion. Days with oxygen supply and pharmacological treatments received were recorded from the clinical chart. A basic asthma hospitalization basket was defined in order to estimate the average hospitalization cost for a single patient. Six months after discharge, new visits to the Emergency Room (ER), use of systemic corticosteroids and adherence to the controller treatment were evaluated. RESULTS 396 patients were enrolled. Patients from the public health system and from the north zone received significantly more days of oxygen, systemic corticosteroids and antibiotics. Great heterogeneity in antibiotic use among the participating hospitals was found, from 0 to 92.3% (ICC 0.34, 95% CI 0.16-0.52). The use of aminophylline, magnesium sulfate and ketamine varied from 0 to 36.4% between the different Pediatric Intensive Care Units (ICC 0.353, 95% CI 0.010-0.608). The average cost per inpatient was of $1910 USD. 290 patients (73.2%) completed the follow-up six months after discharge. 76 patients (26.2%) were not receiving any controller treatment and nearly a fourth had new ER visits and use of systemic corticosteroids due to new asthma exacerbations. CONCLUSIONS Considerable practice variation in asthma exacerbations treatment was found among the participating hospitals, highlighting the poor outcome of many patients after hospital discharge, with an important health cost.
Collapse
Affiliation(s)
- A M Herrera
- Santa María Clinic, Santa María 500, Santiago, Zip Code 7520378 Región Metropolitana, Chile; School of Medicine, Los Andes University, Monseñor Alvaro del Portillo 12455, Santiago, Zip Code 7620001 Región Metropolitana, Chile.
| | - P Brand
- Isala Women's and Children's Hospital, Zwolle, The Netherlands
| | - G Cavada
- School of Medicine, Finis Terrae University, Av Providencia 1509, Santiago, Zip Code 7501015 Región Metropolitana, Chile
| | - A Koppmann
- San Borja Arriarán Hospital, Av Santa Rosa 1234, Santiago, Zip Code 8360160 Región Metropolitana, Chile; School of Medicine, University of Chile, Chile
| | - M Rivas
- San Borja Arriarán Hospital, Av Santa Rosa 1234, Santiago, Zip Code 8360160 Región Metropolitana, Chile
| | - J Mackenney
- Roberto del Río Hospital, Av Profesor Zañartu 1085, Santiago, Zip Code 8380418 Región Metropolitana, Chile; School of Medicine, University of Chile, Chile
| | - H Sepúlveda
- Luis Calvo Mackenna Hospital, Av Antonio Varas 360, Santiago, Zip Code 7500539 Región Metropolitana, Chile
| | - M E Wevar
- Luis Calvo Mackenna Hospital, Av Antonio Varas 360, Santiago, Zip Code 7500539 Región Metropolitana, Chile
| | - L Cruzat
- Luis Calvo Mackenna Hospital, Av Antonio Varas 360, Santiago, Zip Code 7500539 Región Metropolitana, Chile
| | - S Soto
- Concepción Regional Hospital, San Martín 1436, Concepción, Zip Code 4070038 Región del Bío Bío, Chile
| | - M A Pérez
- Santa María Clinic, Santa María 500, Santiago, Zip Code 7520378 Región Metropolitana, Chile
| | - A León
- Santa María Clinic, Santa María 500, Santiago, Zip Code 7520378 Región Metropolitana, Chile
| | - I Contreras
- Padre Hurtado Hospital, Esperanza 2150, Santiago, Zip Code 8880465 Región Metropolitana, Chile
| | - C Alvarez
- Alemana Clinic, Av Vitacura 5951, Santiago, Zip Code 7650568 Región Metropolitana, Chile; School of Medicine, Desarrollo University, Av Las Condes 12496, Santiago, Zip Code 7590943 Región Metropolitana, Chile
| | - B Walker
- Alemana Clinic, Av Vitacura 5951, Santiago, Zip Code 7650568 Región Metropolitana, Chile; School of Medicine, Desarrollo University, Av Las Condes 12496, Santiago, Zip Code 7590943 Región Metropolitana, Chile
| | - C Flores
- Ovalle Hospital, Ariztía Pte. 7, Ovalle, Zip Code 1842054 Región de Coquimbo, Chile
| | - V Lezana
- Gustavo Fricke Hospital, Av Alvarez 1532, Viña del Mar, Zip Code 2570017 Región de Valparaíso, Chile
| | - C Garrido
- Gustavo Fricke Hospital, Av Alvarez 1532, Viña del Mar, Zip Code 2570017 Región de Valparaíso, Chile
| | - M E Herrera
- José Joaquín Aguirre Hospital, Santos Dumont 999, Santiago, Zip Code 8380456 Región Metropolitana, Chile
| | - A Rojas
- José Joaquín Aguirre Hospital, Santos Dumont 999, Santiago, Zip Code 8380456 Región Metropolitana, Chile
| | - C Andrades
- Valdivia Hospital, Coronel Santiago Bueras y Avaria 1003, Valdivia, Zip Code 5090146 Región de los Ríos, Chile
| | - E Chala
- Fusat Hospital, Carretera el Cobre Presidente Frei Montalva 1002, Zip Code 2820945 Rancagua, VI Región, Chile; School of Medicine, Los Andes University, Monseñor Alvaro del Portillo 12455, Santiago, Zip Code 7620001 Región Metropolitana, Chile
| | - R A Martínez
- Fusat Hospital, Carretera el Cobre Presidente Frei Montalva 1002, Zip Code 2820945 Rancagua, VI Región, Chile
| | - M Vega
- Leonardo Guzmán Hospital, Veintiuno de Mayo 1310, Zip Code 1271847 Antofagasta, Región de Antofagasta, Chile
| | - J A Perillán
- San Juan De Dios Hospital, Huérfanos 3255, Zip Code 8350488 Santiago, Región Metropolitana, Chile; School of Medicine, University of Chile, Chile
| | - H Seguel
- San Juan De Dios Hospital, Huérfanos 3255, Zip Code 8350488 Santiago, Región Metropolitana, Chile
| | - I Przybyzsweski
- San Juan De Dios Hospital, Huérfanos 3255, Zip Code 8350488 Santiago, Región Metropolitana, Chile
| |
Collapse
|
22
|
Miñambres E, Cifrian J, Alvarez C, Suberviola B, Fernandez B, Sanchez L, Iturbe D, Ballesteros M. Excellent Long-Term Outcome with Lungs Obtained from Uncontrolled Donation after Circulatory Death. J Heart Lung Transplant 2019. [DOI: 10.1016/j.healun.2019.01.856] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022] Open
|
23
|
Cleveland R, Alvarez C, Schwartz T, Losina E, Renner J, Jordan J, Callahan L. The impact of painful knee osteoarthritis on mortality: a community-based cohort study with over 24 years of follow-up. Osteoarthritis Cartilage 2019; 27:593-602. [PMID: 30583096 PMCID: PMC7063854 DOI: 10.1016/j.joca.2018.12.008] [Citation(s) in RCA: 42] [Impact Index Per Article: 8.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/22/2018] [Revised: 11/14/2018] [Accepted: 12/03/2018] [Indexed: 02/02/2023]
Abstract
OBJECTIVE To investigate the impact of knee osteoarthritis (OA) and/or knee pain on excess mortality. METHOD We analyzed data from 4,182 participants in a community-based prospective cohort study of African American and Caucasian men and women aged ≥45 years. Participants completed knee radiographs and questionnaires at baseline and at up to three follow-ups to determine knee OA (rOA), knee pain and covariate status. Mortality was determined through 2015. We used Cox proportional hazards regression with time-varying covariates (TVC) to estimate hazard ratios (HR) and 95% confidence intervals (CI). Additional analyses stratified by sex, race and age were carried out. RESULTS Median follow-up time was 14.6 years during which 1822 deaths occurred. Baseline knee radiographic osteoarthritis (rOA) was 27.7%, 38.8% at first follow-up, 52.6% at second follow-up and 61.9% at the third follow-up. Knee rOA with pain and knee pain alone were both associated with a >15% increase in premature all-cause mortality. In analyses stratified by sex, race and age, associations between knee pain, with or without knee rOA, and all-cause death were found among women, Caucasians, those ≤65 years of age, and those with a body mass index (BMI)≥30, with observed increased risks of death between 21% and 65%. We observed similar, somewhat attenuated, results for cardiovascular disease (CVD) deaths. CONCLUSION In models taking into account variables that change over time, individuals who had knee pain, alone or with knee rOA, had increased mortality. These effects were particularly strong among those obese. Effective interventions to reduce knee pain, particularly those including weight management and prevention of comorbidities, could reduce mortality.
Collapse
Affiliation(s)
- R.J. Cleveland
- Thurston Arthritis Research Center, Department of Medicine, University of North Carolina, Chapel Hill, NC, USA,Address correspondence and reprint requests to: R.J. Cleveland, Thurston Arthritis Research Center, University of North Carolina, 3300 Thurston Building, Campus Box #7280, Chapel Hill, NC 27599-7280, USA. Tel: 1 (919) 966-4533; Fax: 1 (919) 966-1739. (R.J. Cleveland)
| | - C. Alvarez
- Thurston Arthritis Research Center, Department of Medicine, University of North Carolina, Chapel Hill, NC, USA
| | - T.A. Schwartz
- Department of Biostatistics, University of North Carolina, Chapel Hill, NC, USA,School of Nursing, University of North Carolina, Chapel Hill, NC, USA
| | - E. Losina
- Orthopedic and Arthritis Center for Outcomes Research, Department of Orthopedic Surgery, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA,Department of Biostatistics, Boston University School of Public Health, Boston, MA, USA
| | - J.B. Renner
- Department of Radiology, University of North Carolina, Chapel Hill, NC, USA
| | - J.M. Jordan
- Thurston Arthritis Research Center, Department of Medicine, University of North Carolina, Chapel Hill, NC, USA
| | - L.F. Callahan
- Thurston Arthritis Research Center, Department of Medicine, University of North Carolina, Chapel Hill, NC, USA,Department of Orthopaedics, University of North Carolina, Chapel Hill, NC, USA,Department of Social Medicine, University of North Carolina, Chapel Hill, NC, USA
| |
Collapse
|
24
|
Abeysekara AU, Albert A, Alfaro R, Alvarez C, Álvarez JD, Arceo R, Arteaga-Velázquez JC, Avila Rojas D, Ayala Solares HA, Belmont-Moreno E, BenZvi SY, Brisbois C, Caballero-Mora KS, Capistrán T, Carramiñana A, Casanova S, Castillo M, Cotti U, Cotzomi J, Coutiño de León S, De León C, De la Fuente E, Díaz-Vélez JC, Dichiara S, Dingus BL, DuVernois MA, Ellsworth RW, Engel K, Espinoza C, Fang K, Fleischhack H, Fraija N, Galván-Gámez A, García-González JA, Garfias F, González-Muñoz A, González MM, Goodman JA, Hampel-Arias Z, Harding JP, Hernandez S, Hinton J, Hona B, Hueyotl-Zahuantitla F, Hui CM, Hüntemeyer P, Iriarte A, Jardin-Blicq A, Joshi V, Kaufmann S, Kar P, Kunde GJ, Lauer RJ, Lee WH, León Vargas H, Li H, Linnemann JT, Longinotti AL, Luis-Raya G, López-Coto R, Malone K, Marinelli SS, Martinez O, Martinez-Castellanos I, Martínez-Castro J, Matthews JA, Miranda-Romagnoli P, Moreno E, Mostafá M, Nayerhoda A, Nellen L, Newbold M, Nisa MU, Noriega-Papaqui R, Pretz J, Pérez-Pérez EG, Ren Z, Rho CD, Rivière C, Rosa-González D, Rosenberg M, Ruiz-Velasco E, Salesa Greus F, Sandoval A, Schneider M, Schoorlemmer H, Seglar Arroyo M, Sinnis G, Smith AJ, Springer RW, Surajbali P, Taboada I, Tibolla O, Tollefson K, Torres I, Vianello G, Villaseñor L, Weisgarber T, Werner F, Westerhoff S, Wood J, Yapici T, Yodh G, Zepeda A, Zhang H, Zhou H. Publisher Correction: Very-high-energy particle acceleration powered by the jets of the microquasar SS 433. Nature 2018; 564:E38. [PMID: 30482938 DOI: 10.1038/s41586-018-0688-8] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Abstract
In this Letter, owing to a production error, the penultimate version of the PDF was published. The HTML version was always correct. The PDF has been corrected online.
Collapse
Affiliation(s)
- A U Abeysekara
- Department of Physics and Astronomy, University of Utah, Salt Lake City, UT, USA
| | - A Albert
- Physics and Theoretical Divisions, Los Alamos National Laboratory, Los Alamos, NM, USA
| | - R Alfaro
- Instituto de Física, Universidad Nacional Autónoma de México, Mexico City, Mexico
| | - C Alvarez
- Universidad Autónoma de Chiapas, Tuxtla Gutiérrez, Mexico
| | - J D Álvarez
- Universidad Michoacana de San Nicolás de Hidalgo, Morelia, Mexico
| | - R Arceo
- Universidad Autónoma de Chiapas, Tuxtla Gutiérrez, Mexico
| | | | - D Avila Rojas
- Instituto de Física, Universidad Nacional Autónoma de México, Mexico City, Mexico
| | - H A Ayala Solares
- Department of Physics, Pennsylvania State University, University Park, PA, USA
| | - E Belmont-Moreno
- Instituto de Física, Universidad Nacional Autónoma de México, Mexico City, Mexico
| | - S Y BenZvi
- Department of Physics and Astronomy, University of Rochester, Rochester, NY, USA
| | - C Brisbois
- Department of Physics, Michigan Technological University, Houghton, MI, USA
| | | | - T Capistrán
- Instituto Nacional de Astrofísica, Óptica y Electrónica, Puebla, Mexico
| | - A Carramiñana
- Instituto Nacional de Astrofísica, Óptica y Electrónica, Puebla, Mexico
| | - S Casanova
- Institute of Nuclear Physics Polish Academy of Sciences, IFJ-PAN, Krakow, Poland.,Max-Planck Institute for Nuclear Physics, Heidelberg, Germany
| | - M Castillo
- Universidad Michoacana de San Nicolás de Hidalgo, Morelia, Mexico
| | - U Cotti
- Universidad Michoacana de San Nicolás de Hidalgo, Morelia, Mexico
| | - J Cotzomi
- Facultad de Ciencias Físico Matemáticas, Benemérita Universidad Autónoma de Puebla, Puebla, Mexico
| | - S Coutiño de León
- Instituto Nacional de Astrofísica, Óptica y Electrónica, Puebla, Mexico
| | - C De León
- Facultad de Ciencias Físico Matemáticas, Benemérita Universidad Autónoma de Puebla, Puebla, Mexico
| | - E De la Fuente
- Departamento de Física, Centro Universitario de Ciencias Exactas e Ingenierías, Universidad de Guadalajara, Guadalajara, Mexico
| | - J C Díaz-Vélez
- Departamento de Física, Centro Universitario de Ciencias Exactas e Ingenierías, Universidad de Guadalajara, Guadalajara, Mexico.,Department of Physics and Wisconsin IceCube Particle Astrophysics Center, University of Wisconsin-Madison, Madison, WI, USA
| | - S Dichiara
- Instituto de Astronomía, Universidad Nacional Autónoma de México, Mexico City, Mexico
| | - B L Dingus
- Physics and Theoretical Divisions, Los Alamos National Laboratory, Los Alamos, NM, USA
| | - M A DuVernois
- Department of Physics and Wisconsin IceCube Particle Astrophysics Center, University of Wisconsin-Madison, Madison, WI, USA
| | - R W Ellsworth
- School of Physics, Astronomy, and Computational Sciences, George Mason University, Fairfax, VA, USA
| | - K Engel
- Department of Physics, University of Maryland, College Park, MD, USA
| | - C Espinoza
- Instituto de Física, Universidad Nacional Autónoma de México, Mexico City, Mexico
| | - K Fang
- Department of Astronomy, University of Maryland, College Park, MD, USA.,Joint Space-Science Institute, University of Maryland, College Park, MD, USA
| | - H Fleischhack
- Department of Physics, Michigan Technological University, Houghton, MI, USA
| | - N Fraija
- Instituto de Astronomía, Universidad Nacional Autónoma de México, Mexico City, Mexico
| | - A Galván-Gámez
- Instituto de Astronomía, Universidad Nacional Autónoma de México, Mexico City, Mexico
| | - J A García-González
- Instituto de Física, Universidad Nacional Autónoma de México, Mexico City, Mexico
| | - F Garfias
- Instituto de Astronomía, Universidad Nacional Autónoma de México, Mexico City, Mexico
| | - A González-Muñoz
- Departamento de Física, Centro Universitario de Ciencias Exactas e Ingenierías, Universidad de Guadalajara, Guadalajara, Mexico
| | - M M González
- Instituto de Astronomía, Universidad Nacional Autónoma de México, Mexico City, Mexico
| | - J A Goodman
- Department of Physics, University of Maryland, College Park, MD, USA
| | - Z Hampel-Arias
- Department of Physics and Wisconsin IceCube Particle Astrophysics Center, University of Wisconsin-Madison, Madison, WI, USA.,Inter-university Institute for High Energies, Université Libre de Bruxelles, Brussels, Belgium
| | - J P Harding
- Physics and Theoretical Divisions, Los Alamos National Laboratory, Los Alamos, NM, USA
| | - S Hernandez
- Instituto de Física, Universidad Nacional Autónoma de México, Mexico City, Mexico
| | - J Hinton
- Max-Planck Institute for Nuclear Physics, Heidelberg, Germany
| | - B Hona
- Department of Physics, Michigan Technological University, Houghton, MI, USA
| | | | - C M Hui
- NASA Marshall Space Flight Center, Astrophysics Office, Huntsville, AL, USA
| | - P Hüntemeyer
- Department of Physics, Michigan Technological University, Houghton, MI, USA
| | - A Iriarte
- Instituto de Astronomía, Universidad Nacional Autónoma de México, Mexico City, Mexico
| | - A Jardin-Blicq
- Max-Planck Institute for Nuclear Physics, Heidelberg, Germany
| | - V Joshi
- Max-Planck Institute for Nuclear Physics, Heidelberg, Germany
| | - S Kaufmann
- Universidad Autónoma de Chiapas, Tuxtla Gutiérrez, Mexico
| | - P Kar
- Department of Physics and Astronomy, University of Utah, Salt Lake City, UT, USA
| | - G J Kunde
- Physics and Theoretical Divisions, Los Alamos National Laboratory, Los Alamos, NM, USA
| | - R J Lauer
- Department of Physics and Astronomy, University of New Mexico, Albuquerque, NM, USA
| | - W H Lee
- Instituto de Astronomía, Universidad Nacional Autónoma de México, Mexico City, Mexico
| | - H León Vargas
- Instituto de Física, Universidad Nacional Autónoma de México, Mexico City, Mexico
| | - H Li
- Physics and Theoretical Divisions, Los Alamos National Laboratory, Los Alamos, NM, USA
| | - J T Linnemann
- Department of Physics and Astronomy, Michigan State University, East Lansing, MI, USA
| | - A L Longinotti
- Instituto Nacional de Astrofísica, Óptica y Electrónica, Puebla, Mexico
| | - G Luis-Raya
- Universidad Politecnica de Pachuca, Pachuca, Mexico
| | | | - K Malone
- Department of Physics, Pennsylvania State University, University Park, PA, USA
| | - S S Marinelli
- Department of Physics and Astronomy, Michigan State University, East Lansing, MI, USA
| | - O Martinez
- Facultad de Ciencias Físico Matemáticas, Benemérita Universidad Autónoma de Puebla, Puebla, Mexico
| | | | - J Martínez-Castro
- Centro de Investigación en Computación, Instituto Politécnico Nacional, Mexico City, Mexico
| | - J A Matthews
- Department of Physics and Astronomy, University of New Mexico, Albuquerque, NM, USA
| | | | - E Moreno
- Facultad de Ciencias Físico Matemáticas, Benemérita Universidad Autónoma de Puebla, Puebla, Mexico
| | - M Mostafá
- Department of Physics, Pennsylvania State University, University Park, PA, USA
| | - A Nayerhoda
- Institute of Nuclear Physics Polish Academy of Sciences, IFJ-PAN, Krakow, Poland
| | - L Nellen
- Instituto de Ciencias Nucleares, Universidad Nacional Autónoma de Mexico, Mexico City, Mexico
| | - M Newbold
- Department of Physics and Astronomy, University of Utah, Salt Lake City, UT, USA
| | - M U Nisa
- Department of Physics and Astronomy, University of Rochester, Rochester, NY, USA
| | | | - J Pretz
- Department of Physics, Pennsylvania State University, University Park, PA, USA
| | | | - Z Ren
- Department of Physics and Astronomy, University of New Mexico, Albuquerque, NM, USA
| | - C D Rho
- Department of Physics and Astronomy, University of Rochester, Rochester, NY, USA.
| | - C Rivière
- Department of Physics, University of Maryland, College Park, MD, USA
| | - D Rosa-González
- Instituto Nacional de Astrofísica, Óptica y Electrónica, Puebla, Mexico
| | - M Rosenberg
- Department of Physics, Pennsylvania State University, University Park, PA, USA
| | - E Ruiz-Velasco
- Max-Planck Institute for Nuclear Physics, Heidelberg, Germany
| | - F Salesa Greus
- Institute of Nuclear Physics Polish Academy of Sciences, IFJ-PAN, Krakow, Poland
| | - A Sandoval
- Instituto de Física, Universidad Nacional Autónoma de México, Mexico City, Mexico
| | - M Schneider
- Santa Cruz Institute for Particle Physics, University of California, Santa Cruz, Santa Cruz, CA, USA
| | - H Schoorlemmer
- Max-Planck Institute for Nuclear Physics, Heidelberg, Germany
| | - M Seglar Arroyo
- Department of Physics, Pennsylvania State University, University Park, PA, USA
| | - G Sinnis
- Physics and Theoretical Divisions, Los Alamos National Laboratory, Los Alamos, NM, USA
| | - A J Smith
- Department of Physics, University of Maryland, College Park, MD, USA
| | - R W Springer
- Department of Physics and Astronomy, University of Utah, Salt Lake City, UT, USA
| | - P Surajbali
- Max-Planck Institute for Nuclear Physics, Heidelberg, Germany
| | - I Taboada
- School of Physics and Center for Relativistic Astrophysics, Georgia Institute of Technology, Atlanta, GA, USA
| | - O Tibolla
- Universidad Autónoma de Chiapas, Tuxtla Gutiérrez, Mexico
| | - K Tollefson
- Department of Physics and Astronomy, Michigan State University, East Lansing, MI, USA
| | - I Torres
- Instituto Nacional de Astrofísica, Óptica y Electrónica, Puebla, Mexico
| | - G Vianello
- Department of Physics, Stanford University, Stanford, CA, USA
| | - L Villaseñor
- Facultad de Ciencias Físico Matemáticas, Benemérita Universidad Autónoma de Puebla, Puebla, Mexico
| | - T Weisgarber
- Department of Physics and Wisconsin IceCube Particle Astrophysics Center, University of Wisconsin-Madison, Madison, WI, USA
| | - F Werner
- Max-Planck Institute for Nuclear Physics, Heidelberg, Germany
| | - S Westerhoff
- Department of Physics and Wisconsin IceCube Particle Astrophysics Center, University of Wisconsin-Madison, Madison, WI, USA
| | - J Wood
- Department of Physics and Wisconsin IceCube Particle Astrophysics Center, University of Wisconsin-Madison, Madison, WI, USA
| | - T Yapici
- Department of Physics and Astronomy, University of Rochester, Rochester, NY, USA
| | - G Yodh
- Department of Physics and Astronomy, University of California, Irvine, Irvine, CA, USA
| | - A Zepeda
- Universidad Autónoma de Chiapas, Tuxtla Gutiérrez, Mexico.,Physics Department, Centro de Investigación y de Estudios Avanzados del IPN, Mexico City, Mexico
| | - H Zhang
- Department of Physics and Astronomy, Purdue University, West Lafayette, IN, USA
| | - H Zhou
- Physics and Theoretical Divisions, Los Alamos National Laboratory, Los Alamos, NM, USA.
| |
Collapse
|
25
|
Herrera A, Brand P, Cavada G, Koppmann A, Rivas M, Mackenney J, Sepúlveda H, Wevar M, Cruzat L, Soto S, Pérez M, León A, Contreras I, Alvarez C, Walker B, Flores C, Lezana V, Garrido C, Herrera M, Rojas A, Andrades C, Chala E, Martínez R, Vega M, Perillán J, Seguel H, Przybyzsweski I. Hospitalizations for asthma exacerbation in Chilean children: A multicenter observational study. Allergol Immunopathol (Madr) 2018; 46:533-538. [PMID: 29720350 DOI: 10.1016/j.aller.2018.02.006] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/28/2017] [Revised: 02/06/2018] [Accepted: 02/22/2018] [Indexed: 11/24/2022]
Abstract
BACKGROUND Asthma hospitalization rates in Chilean children have increased in the last 14 years, but little is known about the factors associated with this. OBJECTIVE Describe clinical characteristics of children hospitalized for asthma exacerbation. METHODS Observational prospective cohort study in 14 hospitals. Over a one-year period, children five years of age or older hospitalized with asthma exacerbation were eligible for inclusion. Parents completed an online questionnaire with questions on demographic information, about asthma, indoor environmental contaminant exposure, comorbidities and beliefs about disease and treatment. Disease control was assessed by the Asthma Control Test. Inhalation technique was observed using a checklist. RESULTS 396 patients were enrolled. 168 children did not have an established diagnosis of asthma. Only 188 used at least one controller treatment at the time of hospitalization. 208 parents said they believed their child had asthma only when they had an exacerbation and 97 correctly identified inhaled corticosteroids as anti-inflammatory treatment. 342 patients used the wrong spacer and 73 correctly performed all steps of the checklist. CONCLUSIONS Almost half of the patients were not diagnosed with asthma at the time of hospitalization despite having a medical history suggestive of the disease. In the remaining patients with an established diagnosis of asthma potentially modifiable factors like bad adherence to treatment and poor inhalation technique were found. Implementing a nationwide asthma program including continued medical education for the correct diagnosis and follow up of these patients and asthma education for patients and caregivers is needed to reduce asthma hospitalization rates in Chilean children.
Collapse
|
26
|
Hernando Cubero J, Grande E, Jimenez Fonseca P, Villabona C, Trigo Perez J, Martinez Trufero J, Pajares Bernad I, Lopez C, Alonso T, Biarnes J, RamónY Cajal T, Duran M, Grau J, Arevalo Lobera S, Mesia Nin R, Llanos M, Dalmau Portulas E, Alvarez C, Zafon C, Capdevila J. Efficacy and safety of vandetanib for patients with advanced and progressive medullary thyroid cancer (MTC) as systemic treatment beyond first-line therapy. Ann Oncol 2018. [DOI: 10.1093/annonc/mdy293.022] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
27
|
Juan Fita M, Heras Lopez L, Mellado B, Mendez Vidal M, Anido U, Lorente D, Sepulveda J, Alvarez C. Phase II trial evaluating olaparib maintenance in patients with MCRPC after docetaxel treatment reaching partial or stable response. Ann Oncol 2018. [DOI: 10.1093/annonc/mdy284.069] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
28
|
Díez B, Cuadrado P, Marcos-Fernández Á, de la Campa JG, Tena A, Prádanos P, Palacio L, Lee YM, Alvarez C, Lozano ÁE, Hernández A. Thermally rearranged polybenzoxazoles made from poly(ortho-hydroxyamide)s. Characterization and evaluation as gas separation membranes. REACT FUNCT POLYM 2018. [DOI: 10.1016/j.reactfunctpolym.2018.03.013] [Citation(s) in RCA: 14] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/17/2022]
|
29
|
Monasterio G, Castillo F, Rojas L, Cafferata EA, Alvarez C, Carvajal P, Núñez C, Flores G, Díaz W, Vernal R. Th1/Th17/Th22 immune response and their association with joint pain, imagenological bone loss, RANKL expression and osteoclast activity in temporomandibular joint osteoarthritis: A preliminary report. J Oral Rehabil 2018; 45:589-597. [PMID: 29761933 DOI: 10.1111/joor.12649] [Citation(s) in RCA: 34] [Impact Index Per Article: 5.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 05/09/2018] [Indexed: 12/27/2022]
Abstract
It is well accepted that the presence of cytokines belonging to the Th1/Th17/Th22 axis of immuno-inflammatory response in the joint environment, such as IL-1β, IL-17 and IL-22, respectively, are associated with pathogenesis of several synovial joint degenerative disorders. During temporomandibular joint osteoarthritis (TMJ-OA), IL-1β and IL-17 have been implicated in the inflammation and resorption of sub-chondral bone; however, the role of Th22 response in the TMJ-OA pathophysiology has not been established. This study aimed to compare the expression of Th1/Th17/Th22-type cytokines, chemokines and chemokine receptors in synovial fluid samples obtained from TMJ-OA or disk displacement with reduction (DDWR) patients. In addition, it aimed to associate these levels with joint pain, imagenological signs of bone degeneration, RANKL production, osteoclastogenesis and osteoclast-induced bone resorption. Higher levels of IL-1β, IL-17 and IL-22 were expressed in TMJ-OA compared with DDWR subjects, and these increased levels significantly correlated with RANKL expression, joint pain and articular bone degeneration. Higher levels of CCR5, CCR6 and CCR7, as well as their respective ligands CCL5 and CCL20, responsible for recruitment of IL-1β, IL-17 and IL-22-producing cells, were over-expressed in TMJ-OA compared with DDWR subjects. Osteoclastogenesis and osteoclast-induced bone resorption were significantly greater in presence of synovial fluid from TMJ-OA compared with DDWR subjects. These data demonstrate that cytokines, CCLs and CCRs associated with the Th1/Th17/Th22 axis of immuno-inflammatory response are involved in TMJ-OA pathogenesis. These findings suggest that IL-22 is involved in the RANKL expression in TMJ-OA, which in turn induces differentiation of osteoclasts and subsequent resorption of sub-chondral bone.
Collapse
Affiliation(s)
- G Monasterio
- Periodontal Biology Laboratory, Faculty of Dentistry, Universidad de Chile, Santiago, Chile
| | - F Castillo
- Periodontal Biology Laboratory, Faculty of Dentistry, Universidad de Chile, Santiago, Chile
| | - L Rojas
- Periodontal Biology Laboratory, Faculty of Dentistry, Universidad de Chile, Santiago, Chile
| | - E A Cafferata
- Periodontal Biology Laboratory, Faculty of Dentistry, Universidad de Chile, Santiago, Chile.,Faculty of Dentistry, Universidad Peruana Cayetano Heredia, Lima, Perú
| | - C Alvarez
- Periodontal Biology Laboratory, Faculty of Dentistry, Universidad de Chile, Santiago, Chile.,Department of Oral Pathology, Faculty of Dentistry, Universidad Andres Bello, Santiago, Chile
| | - P Carvajal
- Department of Conservative Dentistry, Faculty of Dentistry, Universidad de Chile, Santiago, Chile
| | - C Núñez
- Department of Oral and Maxillofacial Surgery, Faculty of Dentistry, Universidad de Chile, Santiago, Chile
| | - G Flores
- Department of Prosthesis, Faculty of Dentistry, Universidad de Chile, Santiago, Chile
| | - W Díaz
- Department of Prosthesis, Faculty of Dentistry, Universidad de Chile, Santiago, Chile
| | - R Vernal
- Periodontal Biology Laboratory, Faculty of Dentistry, Universidad de Chile, Santiago, Chile.,Dentistry Unit, Faculty of Health Sciences, Universidad Autónoma de Chile, Santiago, Chile
| |
Collapse
|
30
|
Abeysekara A, Albert A, Alfaro R, Alvarez C, Álvarez J, Arceo R, Arteaga-Velázquez J, Avila Rojas D, Ayala Solares H, Belmont-Moreno E, BenZvi S, Braun J, Brisbois C, Caballero-Mora K, Capistrán T, Carramiñana A, Casanova S, Castillo M, Cotti U, Cotzomi J, Coutiño de León S, De León C, De la Fuente E, Diaz Hernandez R, Dichiara S, Dingus B, DuVernois M, Ellsworth R, Engel K, Enríquez-Rivera O, Fleischhack H, Fraija N, Galván-Gámez A, García-González J, González Muñoz A, González M, Hampel-Arias Z, Harding J, Hernandez S, Hona B, Hueyotl-Zahuantitla F, Hui C, Hüntemeyer P, Iriarte A, Jardin-Blicq A, Joshi V, Kaufmann S, Lara A, Lee W, León Vargas H, Linnemann J, Longinotti A, Luis-Raya G, Luna-García R, López-Coto R, Malone K, Marinelli S, Martinez O, Martinez-Castellanos I, Martínez-Castro J, Martínez-Huerta H, Matthews J, Miranda-Romagnoli P, Moreno E, Mostafá M, Nellen L, Newbold M, Nisa M, Noriega-Papaqui R, Pelayo R, Pretz J, Pérez-Pérez E, Ren Z, Rho C, Rivière C, Rosa-González D, Rosenberg M, Ruiz-Velasco E, Salesa Greus F, Sandoval A, Schneider M, Schoorlemmer H, Seglar Arroyo M, Sinnis G, Smith A, Springer R, Surajbali P, Taboada I, Tibolla O, Torres I, Villaseñor L, Weisgarber T, Westerhoff S, Wood J, Yapici T, Yodh G, Zepeda A, Zhou H. Constraining the
p¯/p
ratio in TeV cosmic rays with observations of the Moon shadow by HAWC. Int J Clin Exp Med 2018. [DOI: 10.1103/physrevd.97.102005] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
|
31
|
Abeysekara AU, Albert A, Alfaro R, Alvarez C, Álvarez JD, Arceo R, Arteaga-Velázquez JC, Avila Rojas D, Ayala Solares HA, Barber AS, Bautista-Elivar N, Becerril A, Belmont-Moreno E, BenZvi SY, Berley D, Bernal A, Braun J, Brisbois C, Caballero-Mora KS, Capistrán T, Carramiñana A, Casanova S, Castillo M, Cotti U, Cotzomi J, Coutiño de León S, De León C, De la Fuente E, Dingus BL, DuVernois MA, Díaz-Vélez JC, Ellsworth RW, Engel K, Enríquez-Rivera O, Fiorino DW, Fraija N, García-González JA, Garfias F, Gerhardt M, González Muñoz A, González MM, Goodman JA, Hampel-Arias Z, Harding JP, Hernández S, Hernández-Almada A, Hinton J, Hona B, Hui CM, Hüntemeyer P, Iriarte A, Jardin-Blicq A, Joshi V, Kaufmann S, Kieda D, Lara A, Lauer RJ, Lee WH, Lennarz D, Vargas HL, Linnemann JT, Longinotti AL, Luis Raya G, Luna-García R, López-Coto R, Malone K, Marinelli SS, Martinez O, Martinez-Castellanos I, Martínez-Castro J, Martínez-Huerta H, Matthews JA, Miranda-Romagnoli P, Moreno E, Mostafá M, Nellen L, Newbold M, Nisa MU, Noriega-Papaqui R, Pelayo R, Pretz J, Pérez-Pérez EG, Ren Z, Rho CD, Rivière C, Rosa-González D, Rosenberg M, Ruiz-Velasco E, Salazar H, Salesa Greus F, Sandoval A, Schneider M, Schoorlemmer H, Sinnis G, Smith AJ, Springer RW, Surajbali P, Taboada I, Tibolla O, Tollefson K, Torres I, Ukwatta TN, Vianello G, Weisgarber T, Westerhoff S, Wisher IG, Wood J, Yapici T, Yodh G, Younk PW, Zepeda A, Zhou H, Guo F, Hahn J, Li H, Zhang H. Extended gamma-ray sources around pulsars constrain the origin of the positron flux at Earth. Science 2018; 358:911-914. [PMID: 29146808 DOI: 10.1126/science.aan4880] [Citation(s) in RCA: 211] [Impact Index Per Article: 35.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/20/2017] [Accepted: 10/09/2017] [Indexed: 11/02/2022]
Abstract
The unexpectedly high flux of cosmic-ray positrons detected at Earth may originate from nearby astrophysical sources, dark matter, or unknown processes of cosmic-ray secondary production. We report the detection, using the High-Altitude Water Cherenkov Observatory (HAWC), of extended tera-electron volt gamma-ray emission coincident with the locations of two nearby middle-aged pulsars (Geminga and PSR B0656+14). The HAWC observations demonstrate that these pulsars are indeed local sources of accelerated leptons, but the measured tera-electron volt emission profile constrains the diffusion of particles away from these sources to be much slower than previously assumed. We demonstrate that the leptons emitted by these objects are therefore unlikely to be the origin of the excess positrons, which may have a more exotic origin.
Collapse
Affiliation(s)
- A U Abeysekara
- Department of Physics and Astronomy, University of Utah, Salt Lake City, UT, USA
| | - A Albert
- Los Alamos National Laboratory, Los Alamos, NM, USA
| | - R Alfaro
- Instituto de Física, Universidad Nacional Autónoma de México, Mexico City, Mexico
| | - C Alvarez
- Universidad Autónoma de Chiapas, Tuxtla Gutiérrez, Chiapas, Mexico
| | - J D Álvarez
- Universidad Michoacana de San Nicolás de Hidalgo, Morelia, Mexico
| | - R Arceo
- Universidad Autónoma de Chiapas, Tuxtla Gutiérrez, Chiapas, Mexico
| | | | - D Avila Rojas
- Instituto de Física, Universidad Nacional Autónoma de México, Mexico City, Mexico
| | - H A Ayala Solares
- Department of Physics, Michigan Technological University, Houghton, MI, USA
| | - A S Barber
- Department of Physics and Astronomy, University of Utah, Salt Lake City, UT, USA
| | | | - A Becerril
- Instituto de Física, Universidad Nacional Autónoma de México, Mexico City, Mexico
| | - E Belmont-Moreno
- Instituto de Física, Universidad Nacional Autónoma de México, Mexico City, Mexico
| | - S Y BenZvi
- Department of Physics and Astronomy, University of Rochester, Rochester, NY, USA
| | - D Berley
- Department of Physics, University of Maryland, College Park, MD, USA
| | - A Bernal
- Instituto de Astronomía, Universidad Nacional Autónoma de México, Mexico City, Mexico
| | - J Braun
- Department of Physics, University of Wisconsin-Madison, Madison, WI, USA
| | - C Brisbois
- Department of Physics, Michigan Technological University, Houghton, MI, USA
| | | | - T Capistrán
- Instituto Nacional de Astrofísica, Óptica y Electrónica, Puebla, Mexico
| | - A Carramiñana
- Instituto Nacional de Astrofísica, Óptica y Electrónica, Puebla, Mexico
| | - S Casanova
- Institute of Nuclear Physics Polish Academy of Sciences, Krakow, Poland.,Max-Planck Institute for Nuclear Physics, Heidelberg, Germany
| | - M Castillo
- Universidad Michoacana de San Nicolás de Hidalgo, Morelia, Mexico
| | - U Cotti
- Universidad Michoacana de San Nicolás de Hidalgo, Morelia, Mexico
| | - J Cotzomi
- Facultad de Ciencias Físico Matemáticas, Benemérita Universidad Autónoma de Puebla, Puebla, Mexico
| | - S Coutiño de León
- Instituto Nacional de Astrofísica, Óptica y Electrónica, Puebla, Mexico
| | - C De León
- Facultad de Ciencias Físico Matemáticas, Benemérita Universidad Autónoma de Puebla, Puebla, Mexico
| | - E De la Fuente
- Departamento de Física, Centro Universitario de Ciencias Exactas e Ingenierías, Universidad de Guadalajara, Guadalajara, Mexico
| | - B L Dingus
- Los Alamos National Laboratory, Los Alamos, NM, USA
| | - M A DuVernois
- Department of Physics, University of Wisconsin-Madison, Madison, WI, USA
| | - J C Díaz-Vélez
- Departamento de Física, Centro Universitario de Ciencias Exactas e Ingenierías, Universidad de Guadalajara, Guadalajara, Mexico
| | - R W Ellsworth
- School of Physics, Astronomy, and Computational Sciences, George Mason University, Fairfax, VA, USA
| | - K Engel
- Department of Physics, University of Maryland, College Park, MD, USA
| | - O Enríquez-Rivera
- Instituto de Geofísica, Universidad Nacional Autónoma de México, Mexico City, Mexico
| | - D W Fiorino
- Department of Physics, University of Maryland, College Park, MD, USA
| | - N Fraija
- Instituto de Astronomía, Universidad Nacional Autónoma de México, Mexico City, Mexico
| | - J A García-González
- Instituto de Física, Universidad Nacional Autónoma de México, Mexico City, Mexico
| | - F Garfias
- Instituto de Astronomía, Universidad Nacional Autónoma de México, Mexico City, Mexico
| | - M Gerhardt
- Department of Physics, Michigan Technological University, Houghton, MI, USA
| | - A González Muñoz
- Instituto de Física, Universidad Nacional Autónoma de México, Mexico City, Mexico
| | - M M González
- Instituto de Astronomía, Universidad Nacional Autónoma de México, Mexico City, Mexico
| | - J A Goodman
- Department of Physics, University of Maryland, College Park, MD, USA
| | - Z Hampel-Arias
- Department of Physics, University of Wisconsin-Madison, Madison, WI, USA
| | - J P Harding
- Los Alamos National Laboratory, Los Alamos, NM, USA
| | - S Hernández
- Instituto de Física, Universidad Nacional Autónoma de México, Mexico City, Mexico
| | - A Hernández-Almada
- Instituto de Física, Universidad Nacional Autónoma de México, Mexico City, Mexico
| | - J Hinton
- Max-Planck Institute for Nuclear Physics, Heidelberg, Germany
| | - B Hona
- Department of Physics, Michigan Technological University, Houghton, MI, USA
| | - C M Hui
- Astrophysics Office, NASA Marshall Space Flight Center Huntsville, AL, USA
| | - P Hüntemeyer
- Department of Physics, Michigan Technological University, Houghton, MI, USA
| | - A Iriarte
- Instituto de Astronomía, Universidad Nacional Autónoma de México, Mexico City, Mexico
| | - A Jardin-Blicq
- Max-Planck Institute for Nuclear Physics, Heidelberg, Germany
| | - V Joshi
- Max-Planck Institute for Nuclear Physics, Heidelberg, Germany
| | - S Kaufmann
- Universidad Autónoma de Chiapas, Tuxtla Gutiérrez, Chiapas, Mexico
| | - D Kieda
- Department of Physics and Astronomy, University of Utah, Salt Lake City, UT, USA
| | - A Lara
- Instituto de Geofísica, Universidad Nacional Autónoma de México, Mexico City, Mexico
| | - R J Lauer
- Department of Physics and Astronomy, University of New Mexico, Albuquerque, NM, USA
| | - W H Lee
- Instituto de Astronomía, Universidad Nacional Autónoma de México, Mexico City, Mexico
| | - D Lennarz
- School of Physics and Center for Relativistic Astrophysics, Georgia Institute of Technology, Atlanta, GA, USA
| | - H León Vargas
- Instituto de Física, Universidad Nacional Autónoma de México, Mexico City, Mexico
| | - J T Linnemann
- Department of Physics and Astronomy, Michigan State University, East Lansing, MI, USA
| | - A L Longinotti
- Instituto Nacional de Astrofísica, Óptica y Electrónica, Puebla, Mexico
| | - G Luis Raya
- Universidad Politecnica de Pachuca, Pachuca, Hidalgo, Mexico
| | - R Luna-García
- Centro de Investigación en Computación, Instituto Politécnico Nacional, Mexico City, Mexico
| | - R López-Coto
- Max-Planck Institute for Nuclear Physics, Heidelberg, Germany.
| | - K Malone
- Department of Physics, Pennsylvania State University, University Park, PA, USA
| | - S S Marinelli
- Department of Physics and Astronomy, Michigan State University, East Lansing, MI, USA
| | - O Martinez
- Facultad de Ciencias Físico Matemáticas, Benemérita Universidad Autónoma de Puebla, Puebla, Mexico
| | | | - J Martínez-Castro
- Centro de Investigación en Computación, Instituto Politécnico Nacional, Mexico City, Mexico
| | - H Martínez-Huerta
- Physics Department, Centro de Investigacion y de Estudios Avanzados del IPN, Mexico City, Mexico
| | - J A Matthews
- Department of Physics and Astronomy, University of New Mexico, Albuquerque, NM, USA
| | | | - E Moreno
- Facultad de Ciencias Físico Matemáticas, Benemérita Universidad Autónoma de Puebla, Puebla, Mexico
| | - M Mostafá
- Department of Physics, Pennsylvania State University, University Park, PA, USA
| | - L Nellen
- Instituto de Ciencias Nucleares, Universidad Nacional Autónoma de México, Mexico City, Mexico
| | - M Newbold
- Department of Physics and Astronomy, University of Utah, Salt Lake City, UT, USA
| | - M U Nisa
- Department of Physics and Astronomy, University of Rochester, Rochester, NY, USA
| | | | - R Pelayo
- Centro de Investigación en Computación, Instituto Politécnico Nacional, Mexico City, Mexico
| | - J Pretz
- Department of Physics, Pennsylvania State University, University Park, PA, USA
| | - E G Pérez-Pérez
- Universidad Politecnica de Pachuca, Pachuca, Hidalgo, Mexico
| | - Z Ren
- Department of Physics and Astronomy, University of New Mexico, Albuquerque, NM, USA
| | - C D Rho
- Department of Physics and Astronomy, University of Rochester, Rochester, NY, USA
| | - C Rivière
- Department of Physics, University of Maryland, College Park, MD, USA
| | - D Rosa-González
- Instituto Nacional de Astrofísica, Óptica y Electrónica, Puebla, Mexico
| | - M Rosenberg
- Department of Physics, Pennsylvania State University, University Park, PA, USA
| | - E Ruiz-Velasco
- Instituto de Física, Universidad Nacional Autónoma de México, Mexico City, Mexico
| | - H Salazar
- Facultad de Ciencias Físico Matemáticas, Benemérita Universidad Autónoma de Puebla, Puebla, Mexico
| | - F Salesa Greus
- Institute of Nuclear Physics Polish Academy of Sciences, Krakow, Poland.
| | - A Sandoval
- Instituto de Física, Universidad Nacional Autónoma de México, Mexico City, Mexico
| | - M Schneider
- Santa Cruz Institute for Particle Physics, University of California, Santa Cruz, Santa Cruz, CA, USA
| | - H Schoorlemmer
- Max-Planck Institute for Nuclear Physics, Heidelberg, Germany
| | - G Sinnis
- Los Alamos National Laboratory, Los Alamos, NM, USA
| | - A J Smith
- Department of Physics, University of Maryland, College Park, MD, USA
| | - R W Springer
- Department of Physics and Astronomy, University of Utah, Salt Lake City, UT, USA
| | - P Surajbali
- Max-Planck Institute for Nuclear Physics, Heidelberg, Germany
| | - I Taboada
- School of Physics and Center for Relativistic Astrophysics, Georgia Institute of Technology, Atlanta, GA, USA
| | - O Tibolla
- Universidad Autónoma de Chiapas, Tuxtla Gutiérrez, Chiapas, Mexico
| | - K Tollefson
- Department of Physics and Astronomy, Michigan State University, East Lansing, MI, USA
| | - I Torres
- Instituto Nacional de Astrofísica, Óptica y Electrónica, Puebla, Mexico
| | - T N Ukwatta
- Los Alamos National Laboratory, Los Alamos, NM, USA
| | - G Vianello
- Hansen Experimental Physics Laboratory Stanford University, Stanford, CA, USA
| | - T Weisgarber
- Department of Physics, University of Wisconsin-Madison, Madison, WI, USA
| | - S Westerhoff
- Department of Physics, University of Wisconsin-Madison, Madison, WI, USA
| | - I G Wisher
- Department of Physics, University of Wisconsin-Madison, Madison, WI, USA
| | - J Wood
- Department of Physics, University of Wisconsin-Madison, Madison, WI, USA
| | - T Yapici
- Department of Physics and Astronomy, Michigan State University, East Lansing, MI, USA
| | - G Yodh
- Department of Physics and Astronomy, University of California, Irvine, Irvine, CA, USA
| | - P W Younk
- Los Alamos National Laboratory, Los Alamos, NM, USA
| | - A Zepeda
- Physics Department, Centro de Investigacion y de Estudios Avanzados del IPN, Mexico City, Mexico.,Universidad Autónoma de Chiapas, Tuxtla Gutiérrez, Chiapas, Mexico
| | - H Zhou
- Los Alamos National Laboratory, Los Alamos, NM, USA.
| | - F Guo
- Los Alamos National Laboratory, Los Alamos, NM, USA
| | - J Hahn
- Max-Planck Institute for Nuclear Physics, Heidelberg, Germany
| | - H Li
- Los Alamos National Laboratory, Los Alamos, NM, USA
| | - H Zhang
- Los Alamos National Laboratory, Los Alamos, NM, USA
| |
Collapse
|
32
|
Bermejo LA, Alvarez C, Maya EM, Garcia C, de la Campa JG, Lozano AE. Synthesis, characterization and gas separation properties of novel polyimides containing cardo and tert-butyl-m-terphenyl moieties. EXPRESS POLYM LETT 2018. [DOI: 10.3144/expresspolymlett.2018.40] [Citation(s) in RCA: 13] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022] Open
|
33
|
Alfaro R, Alvarez C, Álvarez J, Arceo R, Arteaga-Velázquez J, Avila Rojas D, Ayala Solares H, Barber A, Becerril A, Belmont-Moreno E, BenZvi S, Brisbois C, Caballero-Mora K, Capistrán T, Carramiñana A, Casanova S, Castillo M, Cotti U, Cotzomi J, Coutiño de León S, De León C, De la Fuente E, Diaz Hernandez R, Dichiara S, Dingus B, DuVernois M, Díaz-Vélez J, Ellsworth R, Enriquez-Rivera O, Fiorino D, Fleischhack H, Fraija N, García-González J, González Muñoz A, González M, Goodman J, Hampel-Arias Z, Harding J, Hernandez-Almada A, Hinton J, Hueyotl-Zahuantitla F, Hui C, Hüntemeyer P, Iriarte A, Jardin-Blicq A, Joshi V, Kaufmann S, Lara A, Lauer R, Lennarz D, León Vargas H, Linnemann J, Longinotti A, Luis Raya G, Luna-García R, López-Cámara D, López-Coto R, Malone K, Marinelli S, Martinez O, Martinez-Castellanos I, Martínez-Castro J, Martínez-Huerta H, Matthews J, Miranda-Romagnoli P, Moreno E, Mostafá M, Nellen L, Newbold M, Nisa M, Noriega-Papaqui R, Pelayo R, Pretz J, Pérez-Pérez E, Ren Z, Rho C, Rivière C, Rosa-González D, Rosenberg M, Ruiz-Velasco E, Salesa Greus F, Sandoval A, Schneider M, Schoorlemmer H, Sinnis G, Smith A, Springer R, Surajbali P, Taboada I, Tibolla O, Tollefson K, Torres I, Ukwatta T, Villaseñor L, Weisgarber T, Westerhoff S, Wood J, Yapici T, Zepeda A, Zhou H. All-particle cosmic ray energy spectrum measured by the HAWC experiment from 10 to 500 TeV. Int J Clin Exp Med 2017. [DOI: 10.1103/physrevd.96.122001] [Citation(s) in RCA: 42] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
|
34
|
Díaz-Zúñiga J, Melgar-Rodríguez S, Rojas L, Alvarez C, Monasterio G, Carvajal P, Vernal R. Increased levels of the T-helper 22-associated cytokine (interleukin-22) and transcription factor (aryl hydrocarbon receptor) in patients with periodontitis are associated with osteoclast resorptive activity and severity of the disease. J Periodontal Res 2017; 52:893-902. [PMID: 28393368 DOI: 10.1111/jre.12461] [Citation(s) in RCA: 29] [Impact Index Per Article: 4.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 02/27/2017] [Indexed: 12/24/2022]
Abstract
BACKGROUND AND OBJECTIVE Two new T-helper (Th) phenotypes have been recently described and named Th9 and Th22 lymphocytes; however, their role in the pathogenesis of periodontitis remains unclear. This study was aimed to assess whether Th9 and Th22 lymphocytes, through interleukin (IL)-9 and IL-22 production, respectively, are associated with the severity of periodontitis and bone resorption. MATERIAL AND METHODS Gingival crevicular fluid samples and biopsies were obtained from patients with moderate-to-advanced chronic periodontitis and gingivitis, and healthy controls. The levels for the Th9 and Th22-associated cytokines and master-switch transcription factors Spi-B and aryl hydrocarbon receptor (AhR) were quantified by enzyme-linked immunosorbent assay, real-time reverse-transcription quantitative polymerase chain reaction and flow cytometry. In addition, the osteoclast activity in response to tissue homogenates from periodontitis and healthy samples was analyzed quantifying the number of TRAP-positive cells and areas of bone resorption pits produced, in the presence or absence of recombinant human IL-22 and anti-IL-22 neutralization antibody. RESULTS Higher levels of IL-22 and AhR were detected in patients with periodontitis compared with gingivitis and healthy individuals. In addition, higher levels of IL-9 and Spi-B were detected in gingivitis patients compared with periodontitis and healthy individuals. In patients with periodontitis, a significant positive correlation was detected between secreted levels of IL-22 and clinical attachment level of the sampled periodontal pockets. When osteoclasts were exposed to tissue homogenates obtained from patients with periodontitis, higher levels of resorptive activity were observed as compared with the same cells exposed to tissue homogenates obtained from healthy individuals, and this increment was dependent on the presence and neutralization of IL-22. CONCLUSION Increased levels of IL-22 produced by Th22 lymphocytes are associated with the pathogenesis of periodontitis, in particular, with osteoclast resorptive activity and severity of disease.
Collapse
Affiliation(s)
- J Díaz-Zúñiga
- Periodontal Biology Laboratory, Faculty of Dentistry, Universidad de Chile, Santiago, Chile
- Department of Conservative Dentistry, Faculty of Dentistry, Universidad de Chile, Santiago, Chile
| | - S Melgar-Rodríguez
- Periodontal Biology Laboratory, Faculty of Dentistry, Universidad de Chile, Santiago, Chile
- Department of Conservative Dentistry, Faculty of Dentistry, Universidad de Chile, Santiago, Chile
| | - L Rojas
- Periodontal Biology Laboratory, Faculty of Dentistry, Universidad de Chile, Santiago, Chile
| | - C Alvarez
- Periodontal Biology Laboratory, Faculty of Dentistry, Universidad de Chile, Santiago, Chile
| | - G Monasterio
- Periodontal Biology Laboratory, Faculty of Dentistry, Universidad de Chile, Santiago, Chile
| | - P Carvajal
- Department of Conservative Dentistry, Faculty of Dentistry, Universidad de Chile, Santiago, Chile
| | - R Vernal
- Periodontal Biology Laboratory, Faculty of Dentistry, Universidad de Chile, Santiago, Chile
- Dentistry Unit, Faculty of Health Sciences, Universidad Autónoma de Chile, Santiago, Chile
| |
Collapse
|
35
|
Baldwin MK, Alvarez C, Rincon M, Quintero A, Urrego M, Guerra C, Edna F, Taborda N, Hersh AR, Muñoz LF, Moreno DJ, Rubio ML, Vargas JC, Tolosa JE. An implementation strategy to increase uptake of immediate postpartum contraception: the COMSE trial. Contraception 2017. [DOI: 10.1016/j.contraception.2017.07.117] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
|
36
|
Hersh AR, Muñoz LF, Rincon M, Alvarez C, Tolosa JE, Moreno DJ, Rubio ML, Vargas JC, Edna F, Taborda N, Baldwin MK. Video vs. conversational contraceptive counseling during maternity hospitalization: the COMSE trial. Contraception 2017. [DOI: 10.1016/j.contraception.2017.07.113] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
37
|
Loughlin G, Gonzalez-Torrecilla E, Peinado R, Alvarez C, Hernandez Hernandez J, Bravo Calero L, Avila P, Datino T, Atienza F, Arenal A, Fernandez-Aviles F. P5492Is ESC guidelines class of recommendation associated with differences in cardiac resynchronization therapy response rates? Eur Heart J 2017. [DOI: 10.1093/eurheartj/ehx493.p5492] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
38
|
Arajo L, Amante M, Alvarez C, Sousa I. POTENTIALITIES OF MEMORY CAFéS IN SUPPORTING PEOPLE WITH DEMENTIA AND THEIR CARERS. Innov Aging 2017. [DOI: 10.1093/geroni/igx004.631] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Affiliation(s)
- L. Arajo
- ESEV, CI&DETS.IPV, Viseu, Portugal,
- CINTESIS, UNIFAI.ICBAS, Porto, Portugal,
| | | | - C. Alvarez
- Portuguese Alzheimer Portugal, Lisboa, Portugal
| | - I. Sousa
- Portuguese Alzheimer Portugal, Lisboa, Portugal
| |
Collapse
|
39
|
Loughlin G, Gonzalez-Torrecilla E, Peinado R, Alvarez C, Avila P, Datino T, Atienza F, Ruiz-Hernandez P, Arenal A, Fernandez-Aviles F. P440One-year outcomes of cardiac resynchronization therapy in non-ambulatory NYHA class IV heart failure patients. Europace 2017. [DOI: 10.1093/ehjci/eux141.163] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
40
|
Moncada J, Terraza C, Tagle L, Coll D, Ortiz P, Pérez G, de la Campa J, Alvarez C, Tundidor-Camba A. Synthesis, characterization and studies of properties of six polyimides derived from two new aromatic diamines containing a central silicon atom. Eur Polym J 2017. [DOI: 10.1016/j.eurpolymj.2017.04.023] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|
41
|
Ahumada M, Calderon C, Lissi E, Alvarez C, Lanio M, Pazos F. The pore forming capacity of Sticholysin I in dipalmitoyl phosphatidyl vesicles is tuned by osmotic stress. Chem Phys Lipids 2017; 203:87-93. [DOI: 10.1016/j.chemphyslip.2016.12.005] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/17/2016] [Revised: 12/28/2016] [Accepted: 12/28/2016] [Indexed: 11/25/2022]
|
42
|
Alvarez C, Huidobro A, Tejada M, Vázquez I, De Miguel E, Gómez de Segura I. Consequences of frozen storage for nutritional value of hake / Consecuencias del almacenamiento en congelación en el valor nutricional de merluza. FOOD SCI TECHNOL INT 2016. [DOI: 10.1177/108201329900500607] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
Abstract
Differences between fresh and frozen hake muscle in which proteins were highly aggregated during frozen storage, and their relationship with nutritional quality are evaluated. The differences between fresh and frozen muscle proteins were studied on the basis of protein solubility, type and state of muscle aggregation and amino acid composition. Nutritional value was determined by nitrogen bal ance and amino acid composition in the blood. The high level of aggregation in the frozen muscle was due mainly to disulfide and other covalent bonds. Lysine diminished in frozen muscle and in plasma. Although in frozen fish muscle, proteins were highly aggregated even by disulfide and non- disulfide covalent bonds, nitrogen balance in fresh and frozen fish was similar.
Collapse
Affiliation(s)
- C. Alvarez
- Instituto del Frío, CSIC Ciudad Universitaria s/n, 28040 Madrid, Spain
| | - A. Huidobro
- Instituto del Frío, CSIC Ciudad Universitaria s/n, 28040 Madrid, Spain
| | - M. Tejada
- Instituto del Frío, CSIC Ciudad Universitaria s/n, 28040 Madrid, Spain
| | - I. Vázquez
- Hospital La Paz, Paseo de la Castellana 261, 28046 Madrid, Spain
| | - E. De Miguel
- Hospital La Paz, Paseo de la Castellana 261, 28046 Madrid, Spain
| | | |
Collapse
|
43
|
Alvarez C, Ramirez-Campillo R, Martinez-Salazar C, Mancilla R, Flores-Opazo M, Cano-Montoya J, Ciolac EG. Low-Volume High-Intensity Interval Training as a Therapy for Type 2 Diabetes. Int J Sports Med 2016; 37:723-9. [PMID: 27259099 DOI: 10.1055/s-0042-104935] [Citation(s) in RCA: 45] [Impact Index Per Article: 5.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/17/2022]
Abstract
Our purpose was to investigate the effects of low-volume, high-intensity interval training (HIT) on cardiometabolic risk and exercise capacity in women with type 2 diabetes mellitus (T2DM). Sedentary overweight/obese T2DM women (age=44.5±1.8 years; BMI=30.5±0.6 kg/m(2)) were randomly assigned to a tri-weekly running-based HIT program (n=13) or non-exercise control follow-up (CON; n=10). Glycemic control, lipid and blood pressure levels, endurance performance, and anthropometry were measured before and after the follow-up (16 weeks) in both groups. Medication intake was also assessed throughout the follow-up. Improvements (P<0.05) on fasting glucose (14.3±1.4%), HbA1c (12.8±1.1%), systolic blood pressure (3.7±0.5 mmHg), HDL-cholesterol (21.1±2.8%), triglycerides (17.7±2.8%), endurance performance (9.8±1.0%), body weight (2.2±0.3%), BMI (2.1±0.3%), waist circumference (4.0±0.5%) and subcutaneous fat (18.6±1.4%) were found after HIT intervention. Patients of HIT group also showed reductions in daily dosage of antihyperglycemic and antihypertensive medication during follow-up. No changes were found in any variable of CON group. The HIT-induced improvements occurred with a weekly time commitment 56-25% lower than the minimal recommended in current guidelines. These findings suggest that low-volume HIT may be a time-efficient intervention to treat T2DM women.
Collapse
Affiliation(s)
- C Alvarez
- Cardiovascular Health Program, Centro de Salud Familiar, Los Lagos, Chile
| | - R Ramirez-Campillo
- Department of Physical Activity Sciences, Universidad de Los Lagos, Osorno, Chile
| | - C Martinez-Salazar
- Department of Physical Education and Recreation, Faculty of Education, Social Sciences and Humanities, Universidad de la Frontera, Temuco, Chile
| | - R Mancilla
- Department of Human Movement Science, Faculty of Health, Medicine and Life Sciences, Maastricht University, Maastricht, Netherlands
| | - M Flores-Opazo
- Department of Physiology, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Victoria, Australia
| | - J Cano-Montoya
- Rehabilitation, Public Hospital of Los Lagos, Los Lagos, Chile
| | - E G Ciolac
- Exercise and Chronic Disease Research Laboratory, Physical Education Department, School of Sciences, São Paulo State Univiersity - UNESP
| |
Collapse
|
44
|
Golightly Y, Alvarez C, Cantrell J, Renner J, Helmick C, Jordan J. THU0638 Leg Length Inequality as A Risk Factor for Disability in A Community-Based Longitudinal Study. Ann Rheum Dis 2016. [DOI: 10.1136/annrheumdis-2016-eular.2284] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
45
|
Palomo-Piñon S, Paniagua_Sierra J, Limon F, Mejia O, Alvarez C, Perez C, Chapa L, Zavala J, Cortes L, Lopez J, Jimenez G, Blanco W, Delgado J, Martinez M, Marques J. PM040 Addressing High Blood Pressure Control in Primary Care Office in Mexico. First Report of the IMSS HBP Collaborative Group. Glob Heart 2016. [DOI: 10.1016/j.gheart.2016.03.267] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022] Open
|
46
|
Matos I, Grau JJ, Grande E, Martinez Trufero J, Trigo JM, Lopez C, Manzano JL, Reig Ò, Alvarez C, Beltran M, Duran M, Aller J, Iglesias L, Arevalo S, Manzano A, Mesia R, Reina JJ, Sepúlveda JM, Virizuela JA, Capdevila J. Efficacy of multikinase inhibitors (MKIs) in successive treatment lines of refractory advanced thyroid cancer patients (pts). J Clin Oncol 2016. [DOI: 10.1200/jco.2016.34.15_suppl.e17553] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Affiliation(s)
- Ignacio Matos
- Vall d'Hebron Institute of Oncology, Barcelona, Spain
| | | | - Enrique Grande
- Medical Oncology Department, Hospital Universitario Ramon y Cajal, Madrid, Spain
| | | | | | - Carlos Lopez
- Hospital Universitario Marques de Valdecilla, Santander, Spain
| | - Jose Luis Manzano
- Institut Català d'Oncologia, Hospital Universitario German Trias i Pujol, Badalona, Spain
| | - Òscar Reig
- Translational Genomics and Targeted Therapeutics in Solid Tumors Lab (IDIBAPS), Medical Oncology. Hospital Clínic Barcelona, Barcelona, Spain
| | | | - Miguel Beltran
- Institut Català d'Oncologia Hospital Universitari Josep Trueta, Girona, Spain
| | - Manuel Duran
- Rey Juan Carlos University Hospital, Madrid, Spain
| | - Javier Aller
- Puerta de Hierro University Hospital, Madrid, Spain
| | - Lara Iglesias
- Medical Oncology Dpt, 12 de Octubre Hospital, Madrid, Spain
| | | | | | - Ricard Mesia
- Medical Oncology Department, Institut Català d'Oncologia (ICO) L'Hospitalet, University of Barcelona, Barcelona, Spain
| | - Juan J Reina
- Hospital Universitario Virgen Macarena, Sevilla, Spain
| | | | - JA Virizuela
- Medical Oncology Department. Hospital Universitario Virgen Macarena, Seville, Spain
| | | |
Collapse
|
47
|
Pascual-Martínez T, Apellániz-Ruiz M, Pernaut C, Cueto-Felgueroso C, Villalba P, Alvarez C, Manso L, Rodriguez-Antona C, Ciruelos EM. Abstract P3-07-40: Pharmacogenetic study of exemestane and everolimus in metastatic breast cancer patients progressing on prior non-steroidal aromatase inhibitors. Cancer Res 2016. [DOI: 10.1158/1538-7445.sabcs15-p3-07-40] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Background: Activation of the mTOR pathway has been observed in patients (pts) with metastatic breast cancer (MBC) progressing on endocrine therapy. BOLERO-2 trial demonstrated a significant increase in progression free survival (PFS) obtained with everolimus (EVE) and exemestane (EXE) versus EXE alone in pts refractory to a prior non-steroidal aromatase inhibitors (NSAI). However, there is large interindividual variability in toxicity and efficacy profiles of EXE-EVE treatment. Single Nucleotide Polymorphisms (SNPs) have been proposed to explain some of these differences. The objective of this study was to perform a pharmacogenetic analysis to identify SNPs associated with EVE toxicity and activity.
Methods: This is a prospective unicentric clinical trial for postmenopausal pts with hormone receptor-positive, HER2 negative, MBC progressing on prior NSAI, treated with EXE-EVE.
Blood samples were obtained from all pts, and 12 SNPs in key genes involved in EXE pharmacokinetics (ABCB1, CYP2C8, CYP3A4, CYP3A5) and pharmacodynamics (AKT1, AKT2, FGFR4, PHLPP2, PIK3R1, RAPTOR) were genotyped. EVE pharmacokinetics data was available for a subset of 37 pts. The association between the SNPs and EVE pharmacokinetic parameters were analyzed using U-Mann-Whitney test. A selection of clinically relevant toxicities (non-infectious pneumonitis (NIP), mucositis, hyperglycemia and hematological) was analyzed using binary logistic regression. Cox regression was used to analyze the association of SNPs with time to treatment modifications (reduction or interruption) due to toxicity, PFS and OS.
Results: 90 patients with median age of 62 yrs were included. At data cut off, a total of 77 pts had discontinued treatment. Major reasons for discontinuation were: disease progression (80%), adverse events (17%) and death (2%). Number of prior chemotherapy lines: 0; 50%, 1;18%, 2;10%, ≥3; 22%. 76% of pts experienced at least one adverse event related to EVE.
CYP3A4 rs35599367 (CYP3A4*22 allele) heterozygous pts had higher EVE concentration in blood compared to wild type pts (P=0.019), in agreement with previous data.
Regarding EVE toxicities, ABCB1 SNP rs1045642 showed a higher risk of mucositis (HR=2.3, 95%CI=1.1-4.8, P=0.031; multivariable analysis), and PIK3R1 rs10515074 variant was inversely associated with hyperglycemia (HR=0.24, 95%CI=0.1-0.8, P=0.016; multivariable analysis). RAPTOR rs9906827 protected for NIP (HR=0.38, 95%CI=0.2-0.9, P=0.024; multivariable analysis). When analyzing the time to treatment modification due to any toxicity, we observed a trend for FGFR4 rs351855 and RAPTOR rs9906827 (HR=0.59, 95%CI=0.3-1.0, P=0.06 and HR=0.71, 95%CI=0.5-1.1, P=0.12; respectively, in multivariable analysis).
Regarding activity, RAPTOR rs9906827 was also associated with longer PFS (dominant model HR=0.48, 95%CI=0.3-0.8, P=0.006; multivariable analysis). No SNP was significantly associated with OS.
Conclusions: We found altered EVE pharmacokinetics for CYP3A4*22 carriers and protection for NIP and longer PFS for RAPTOR rs9906827. This study supports prospective trials for genetic testing prior to EXE-EVE therapy to stratify patients according to toxicity and efficacy risk profiles.
Citation Format: Pascual-Martínez T, Apellániz-Ruiz M, Pernaut C, Cueto-Felgueroso C, Villalba P, Alvarez C, Manso L, Rodriguez-Antona C, Ciruelos EM. Pharmacogenetic study of exemestane and everolimus in metastatic breast cancer patients progressing on prior non-steroidal aromatase inhibitors. [abstract]. In: Proceedings of the Thirty-Eighth Annual CTRC-AACR San Antonio Breast Cancer Symposium: 2015 Dec 8-12; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2016;76(4 Suppl):Abstract nr P3-07-40.
Collapse
Affiliation(s)
- T Pascual-Martínez
- Hospital 12 de Octubre, Madrid, Spain; Spanish National Cancer Research Centre (CNIO), Madrid, Spain
| | - M Apellániz-Ruiz
- Hospital 12 de Octubre, Madrid, Spain; Spanish National Cancer Research Centre (CNIO), Madrid, Spain
| | - C Pernaut
- Hospital 12 de Octubre, Madrid, Spain; Spanish National Cancer Research Centre (CNIO), Madrid, Spain
| | - C Cueto-Felgueroso
- Hospital 12 de Octubre, Madrid, Spain; Spanish National Cancer Research Centre (CNIO), Madrid, Spain
| | - P Villalba
- Hospital 12 de Octubre, Madrid, Spain; Spanish National Cancer Research Centre (CNIO), Madrid, Spain
| | - C Alvarez
- Hospital 12 de Octubre, Madrid, Spain; Spanish National Cancer Research Centre (CNIO), Madrid, Spain
| | - L Manso
- Hospital 12 de Octubre, Madrid, Spain; Spanish National Cancer Research Centre (CNIO), Madrid, Spain
| | - C Rodriguez-Antona
- Hospital 12 de Octubre, Madrid, Spain; Spanish National Cancer Research Centre (CNIO), Madrid, Spain
| | - EM Ciruelos
- Hospital 12 de Octubre, Madrid, Spain; Spanish National Cancer Research Centre (CNIO), Madrid, Spain
| |
Collapse
|
48
|
Martins Fernandes S, Badano L, Garcia Campos A, Erdei T, Mehdipoor G, Hanboly N, Michalski BW, Vriz O, Mo VY, Le TT, Ribeiro JM, Ternacle J, Yurdakul SELEN, Shetye A, Stoebe S, Lisowska A, Chinali M, Orabona M, Contaldi C, De La Chica JA, Codolosa JN, Trzcinski P, Prado Diaz S, Morales Portano JD, Ha SJ, Valente F, Joseph G, Valente F, Scali MC, Cordeiro F, Duchateau N, Fabris E, Costantino MF, Cho IJ, Goublaire C, Lam W, Galli E, Kim KH, Mariani M, Malev E, Zuercher F, Tang Z, Cimino S, Mahia P, De La Chica JA, Petrovic J, Ciobotaru V, Remsey- Semmelweiss E, Kogoj P, Guerreiro S, Saxena A, Mozenska O, Pontone G, Macaya Ten F, Caballero L, Avegliano G, Halmai L, Reis L, Trifunovic D, Gospodinova M, Makavos G, D'ascenzi F, Dantas Tavares De Melo M, Bonapace S, Kulkarni A, Cameli M, Ingvarsson A, Driessen MMP, Tufekcioglu O, Radulescu D, Barac A, Cioffi G, Almeida Morais L, Ledakowicz-Polak A, Portugal G, Naksuk N, Parato VM, Kovalova S, Cherubini A, Corrado G, Malev E, Wierzbowska-Drabik K, Lesevic H, Laredj N, Pieles GE, Generati G, Van Zalen JJ, Aquila I, Cheng HL, Lanzoni L, Asmarats Serra L, Kadrabulatova S, Ranjbar S, Szczesniak-Stanczyk D, Sharka I, Di Salvo G, Ben Kahla S, Li L, Hadeed HA, Habeeb HA, Toscano A, Granata F, Djikic D, Wdowiak-Okrojek K, Girgis HYA, Sharma A, Soro C, Gallego Page JC, Corneli M, Teixeira R, Roussin I, Lynch M, Muraru D, Romeo G, Ermacora D, Marotta C, Aruta P, Cucchini U, Iliceto S, Martin-Fernandez M, De La Hera Galarza JM, Corros-Vicente C, Colunga Blanco S, Velasco-Alonso E, Leon-Aguero V, Rodriguez-Suarez ML, Moris De La Tassa C, Edwards J, Braim D, Price C, Fraser AG, Salmani F, Arjmand Shabestari A, Szymczyk E, Kupczynska K, Peczek L, Nawrot B, Lipiec P, Kasprzak JD, Driussi C, Ferrara F, Brosolo G, Antonini-Canterin F, Magne J, Aboyans V, Bossone E, Bellucci BM, Fisher JM, Balekian AA, Idapalapati S, Huang F, Wong JI, Tan RS, Teixeira R, Madeira M, Almeida I, Reis L, Siserman A, Dinis P, Dias L, Ramos AP, Goncalves L, Wan FW, Sawaki DS, Dubois-Rande JLDR, Adnot SA, Czibik GC, Derumeaux GD, Ercan G, Tekkesin ILKER, Sahin ST, Cengiz B, Celik G, Demircan S, Aytekin SAIDE, Razvi NA, Nazir SA, Price N, Khan JN, Kanagala P, Singh A, Squire I, Mccann GP, Langel M, Pfeiffer D, Hagendorff A, Ptaszynska-Kopczynska K, Marcinkiewicz-Siemion M, Knapp M, Witkowski M, Musial WJ, Kaminski K, Natali B, D' Anna C, Leonardi B, Secinaro A, Pongiglione G, Rinelli G, Renard S, Michel N, Mancini J, Haentjens J, Sitbon O, Habib G, Imbriaco M, Alcidi G, Santoro C, Buonauro A, Lo Iudice F, Lembo M, Cuocolo A, Trimarco B, Galderisi M, Mora Robles J, Roldan Jimenez MA, Mancisidor MA, De Mora MA, Alnabelsi T, Goykhman I, Koshkelashvili N, Romero-Corral A, Pressman GS, Michalski BW, Kupczynska K, Miskowiec D, Lipiec P, Kasprzak JD, Montoro Lopez N, Refoyo Salicio E, Valbuena Lopez SC, Gonzalez O, Alvarez C, Moreno Yanguela M, Bartha Rasero JL, De La Calle M, Guzman Martinez G, Suarez-Cuenca JA, Merino JA, Gomez Alvarez EB, Delgado LG, Woo YM, Bang WD, Sohn GH, Cheong SS, Yoo SY, Rodriguez Palomares JF, Gutierrez L, Maldonado G, Pineda V, Galian L, Teixido G, Gonzalez Allujas MT, Evangelista A, Garcia Dorado D, Zaremba T, Ekeloef S, Heiberg E, Engblom H, Jensen SE, Sogaard P, Rodriguez Palomares JF, Gutierrez L, Garcia G, Pineda V, Galian L, Teixido G, Gonzalez Allujas MT, Evangelista A, Garcia Dorado D, Dini FL, Galli F, Lattanzi F, Picano E, Marzilli M, Leao S, Moz M, Magalhaes P, Trigo J, Mateus PS, Ferreira A, Moreira JI, De Craene M, Legallois D, Labombarda F, Pellissier A, Sermesant M, Saloux E, Merlo M, Moretti M, Barbati G, Stolfo D, Gigli M, Pinamonti B, Sinagra G, Dores E, Matera A, Innelli P, Innelli P, Lopizzo A, Violini R, Fiorilli R, Cappabianca G, Picano E, Tarsia G, Seo J, Chang HJ, Heo R, Kim IC, Shim CY, Hong GR, Chung N, Melissopoulou MM, Nguyen V, Brochet E, Cimadevilla C, Codogno I, Vahanian A, Messika-Zeitoun D, Pontana F, Vassiliou V, Prasad S, Leclercq C, Samset E, Donal E, Lim DS, Bianchi G, Rossi F, Gianetti J, Marchi F, Cerone E, Nardelli A, Terrazzi M, Solinas M, Maffei S, Pshepiy A, Vasina L, Timofeev E, Reeva S, Zemtsovsky E, Brugger N, Jahren S, De Marchi SF, Seiler C, Jin CN, Tang H, Fan K, Kam K, Yan BP, Yu CM, Lee PW, Reali M, Silvetti E, Salatino T, Mancone M, Pennacchi M, Giordano A, Sardella G, Agati L, Tirado G, Nogales-Romo MT, Marcos-Alberca P, De Agustin A, Almeria C, Rodrigo JL, Garcia Fernandez MA, Macaya C, Perez De Isla L, Mancisidor M, Lara Garcia C, Vivancos R, De Mora M, Petrovic M, Vujisic-Tesic B, Trifunovic D, Boricic-Kostic M, Petrovic I, Draganic G, Petrovic O, Tomic-Dragovic M, Furlan T, Ambrozic J, Mohorko Pleskovic PN, Bunc M, Ribeiras R, Abecasis J, Andrade MJ, Mendes M, Ramakrishnan S, Gupta SK, Juneja R, Kothari SS, Zaleska M, Segiet A, Chwesiuk S, Kroc A, Kosior DA, Andreini D, Solbiati A, Guglielmo M, Mushtaq S, Baggiano A, Beltrama V, Rota C, Guaricci AI, Pepi M, Pons Llinares J, Asmarats Serra L, Pericas Ramis P, Caldes Llull O, Grau Sepulveda A, Frontera G, Vaquer Segui A, Noris M, Bethencourt Gonzalez A, Climent Paya V, Martinez Moreno M, Saura D, Oliva MJ, Sanchez Quinones J, Garcia Honrubia A, Valdes M, De La Morena G, Terricabras M, Costabel JP, Ronderos R, Evangelista A, Venturini C, Galve E, Nemes A, Neubauer S, Rahman Haley S, Banner N, Teixeira R, Caetano F, Almeida I, Trigo J, Botelho A, Silva J, Nascimento J, Goncalves L, Tesic M, Jovanovic I, Petrovic O, Boricic-Kostic M, Dragovic M, Petrovic M, Stepanovic J, Banovic M, Vujisic-Tesic B, Guergelcheva V, Chamova T, Sarafov S, Tournev I, Denchev S, Ikonomidis I, Psarogiannakopoulos P, Tsirigotis P, Paraskevaidis I, Lekakis J, Pelliccia A, Natali BM, Cameli M, Focardi M, Bonifazi M, Mondillo S, Lima C, Assed L, Kalil Filho R, Mady C, Bochi EA, Salemi VMC, Targher G, Valbusa F, Rossi A, Lanzoni L, Lipari P, Zenari L, Molon G, Canali G, Barbieri E, Li L, Craft M, Nanda M, Lorenzo JM, Kutty S, Bombardini T, Sparla S, Di Tommaso C, Losito M, Incampo E, Maccherini M, Mondillo S, Werther Evaldsson A, Radegran G, Stagmo M, Waktare J, Roijer A, Meurling CJ, Hui W, Meijboom FJ, Bijnens B, Dragulescu A, Mertens L, Friedberg MK, Sensoy B, Suleymanoglu M, Akin Y, Sahan E, Sasmaz H, Pasca L, Buzdugan E, Chis B, Stoicescu L, Lynce FC, Smith KL, Mete M, Isaacs C, Viapiana O, Di Nora C, Ognibeni F, Fracassi E, Giollo A, Mazzone C, Faganello G, Di Lenarda A, Rossini M, Galrinho A, Branco L, Timoteo AT, Rodrigues I, Daniel P, Rosa S, Ferreira L, Ferreira R, Polak L, Krauza G, Stokfisz K, Zielinska M, Branco LM, Galrinho A, Mota Carmo M, Teresa Timoteo A, Aguiar Rosa S, Abreu J, Pinto Teixeira P, Viveiros Monteiro A, Cruz Ferreira R, Peeraphatdit T, Chaiteerakij R, Klarich KW, Masia S, Necas J, Nistri S, Negri F, Barbati G, Cioffi G, Russo G, Mazzone C, Faganello G, Pandullo C, Di Lenarda A, Durante A, Rovelli E, Genchi V, Trabattoni L, Zerboni SC, Cattaneo L, Butti E, Ferrari G, Luneva E, Mitrofanova L, Uspensky V, Zemtsovsky E, Kasprzak JD, Rosner S, Karl M, Ott I, Sonne C, Ali Lahmar HM, Hammou L, Forsey J, Gowing L, Miller F, Ramanujam P, Stuart AG, Williams CA, Bandera F, Pellegrino M, Carbone F, Labate V, Alfonzetti E, Guazzi M, Patel NR, Raju P, Beale L, Brickley G, Lloyd GW, Fernandez-Golfin C, Gonzalez A, Rincon LM, Hinojar R, Garcia A, Megias A, Jimenez-Nacher JJ, Moya JL, Zamorano JL, Molon G, Canali G, Bonapace S, Chiampan A, Albrigi L, Barbieri E, Noris Mora M, Rodriguez Fernandez A, Exposito Pineda C, Grande C, Gonzalez Colino R, Macaya Ten F, Fernandez Vazquez X, Fortuny Frau E, Bethencourt Gonzalez A, Karvandi M, Blaszczyk R, Zarczuk R, Brzozowski W, Janowski M, Wysokinski A, Stanczyk B, Myftiu S, Teferici D, Quka A, Dado E, Djamandi J, Kresto L, Duka A, Kristo A, Balla I, Issa Z, Moiduddin N, Siblini G, Bulbul Z, Abid L, Abid D, Kammoun S, Rush E, Craft M, Goodwin J, Kreikemeier R, Cantinotti M, Kutty S, Zolaly MA, Khoshhal SQ, El-Harbi K, Tarawah A, Al-Hawsawi Z, Al-Mozainy I, Bakhoum SWG, Nabil MN, Elebrashy IN, Chinali M, Albanese S, Carotti A, Iacobelli R, Esposito C, Secinaro A, Moscogiuri G, Pasquini L, Malvezzi Caracciolo M, Bianchi RM, Caso P, Arenga F, Riegler L, Scarafile R, D'andrea A, Russo MG, Calabro' P, Simic DS, Peric VP, Mujovic NM, Marinkovic MM, Jankovic NJ, Shim A, Wejner-Mik P, Kasprzak JD, Lipiec P, Jain N, Kharwar R, Saran RK, Narain VS, Dwivedi SK, Sethi R, Chandra S, Pradhan A, Safal S, Marchetti MF, Cacace C, Congia M, Nissardi V, Ruscazio M, Meloni L, Montisci R, Gallego Sanchez G, Calero S, Portero JJ, Tercero A, Garcia JC, Barambio M, Martinez Lazaro R, Meretta AH, Perea GO, Belcastro F, Aguirre E, De Luca I, Henquin R, Masoli O. Poster session 2THE IMAGING EXAMINATIONP536Appropriate use criteria of transthoracic echocardiography and its clinical impact: a continuous challengeP537Implementation of proprietary plug-ins in the DICOM-based computerized echo reporting system fuels the use of 3D echo and deformation imaging in the clinical routine of a multivendor laboratoryP538Exercise stress echocardiography appropriate use criteria: real-life cases classification ease and agreement among cardiologistsANATOMY AND PHYSIOLOGY OF THE HEART AND GREAT VESSELSP539Functional capacity in older people with normal ejection fraction correlates with left ventricular functional reserve and carotid-femoral pulse wave velocity but not with E/e and augmentation indexP540Survey of competency of practitioners for diagnosis of acute cardiopulmonary diseases manifest on chest x-rayASSESSMENT OF DIAMETERS, VOLUMES AND MASSP541Left atrium remodeling in dialysis patients with normal ejection fractionP542The prediction of postinfarction left ventricular remodeling and the role of of leptin and MCP-1 in regard to the presence of metabolic syndromeP543Ascending aorta and common carotid artery: diameters and stiffness in a group of 584 healthy subjectsAssessments of haemodynamicsP544Alternate echo parameters in patients without estimable RVSPAssessment of systolic functionP545Reduced contractile performance in heart failure with preserved ejection fraction: determination using novel preload-adjusted maximal left ventricular ejection forceP546Left ventricular dimensions and prognosis in acute coronary syndromesP547Time course of myocardial alterations in a murine model of high fat diet: A strain rate imaging studyP548Subclinical left ventricular systolic dysfunction in patients with premature ventricular contractionsP549Global myocardial strain by CMR-based feature tracking (FT) and tagging to predict development of severe left ventricular systolic dysfunction after acute st-elevation myocardial infarctionP550Echocardiographic analysis of left and right ventricular function in patients after mitral valve reconstructionP551The role of regional longitudinal strain assessment in predicting response to cardiac resynchronization therapy in patients with left ventricular systolic dysfunction and left bundle branch blockP552Speckle tracking automatic border detection improves echocardiographic evaluation of right ventricular systolic function in repaired tetralogy of fallot patients: comparison with MRI findingsP553Echocardiography: a reproducible and relevant tool in pah? intermediate results of the multicentric efort echogardiographic substudy (evaluation of prognostic factors and therapeutic targets in pah)Assessment of diastolic functionP554Relationship between left ventricular filling pressures and myocardial fibrosis in patients with uncomplicated arterial hypertensionP555Cardiac rehabilitation improves echocardiographic parameters of diastolic function in patients with ischemic heart diseaseP556Diastolic parameters in the calcified mitral annulusP557Biomarkers and echocardiography - combined weapon to diagnose and prognose heart failure with and without preserved ejection fractionP558Diastolic function changes of the maternal heart in twin and singleton pregnancyIschemic heart diseaseP559Syntax score as predictor for the correlation between epicardial adipose tissue and the severity of coronary lesions in patients with significant coronary diseaseP560Impact of strain analysis in ergonovine stress echocardiography for diagnosis vasospastic anginaP561Cardiac magnetic resonance tissue tracking: a novel method to predict infarct transmurality in acute myocardial infarctionP562Infarct size is correlated to global longitudinal strain but not left ventricular ejection fraction in the early stage of acute myocardial infarctionP563Magnetic resonance myocardial deformation assessment with tissue tracking and risk stratification in acute myocardial infarction patientsP564Increase in regional end-diastolic wall thickness by transthoracic echocardiography as a biomarker of successful reperfusion in anterior ST elevation acute myocardial infarctionP565Mitral regurgitation is associated with worse long-term prognosis in ST-segment elevation myocardial infarction treated with primary percutaneous coronary interventionP566Statistical significance of 3D motion and deformation indexes for the analysis of LAD infarctionHeart valve DiseasesP567Paradoxical low gradient aortic stenosis: echocardiographic progression from moderate to severe diseaseP568The beneficial effects of TAVI in mitral insufficiencyP569Impact of thoracic aortic calcification on the left ventricular hypertrophy and its regression after aortic valve replacement in patients with severe aortic stenosisP570Additional value of exercise-stress echocardiography in asymptomatic patients with aortic valve stenosisP571Valvulo-arterial impedance in severe aortic stenosis: a dual imaging modalities studyP572Left ventricular mechanics: novel tools to evaluate left ventricular performance in patients with aortic stenosisP573Comparison of long-term outcome after percutaneous mitral valvuloplasty versus mitral valve replacement in moderate to severe mitral stenosis with left ventricular dysfunctionP574Incidence of de novo left ventricular dysfunction in patient treated with aortic valve replacement for severe aortic regurgitationP575Transforming growth factor-beta dependant progression of the mitral valve prolapseP576Quantification of mitral regurgitation with multiple jets: in vitro validation of three-dimensional PISA techniqueP577Impaired pre-systolic contraction and saddle-shape deepening of mitral annulus contributes to atrial functional regurgitation: a three-dimensional echocardiographic studyP578Incidence and determinants of left ventricular (lv) reverse remodeling after MitraClip implantation in patients with moderate-to severe or severe mitral regurgitation and reduced lv ejection fractionP579Severe functional tricuspid regurgitation in rheumatic heart valve disease. New insights from 3D transthoracic echocardiographyP58015 years of evolution of the etiologic profile for prosthetic heart valve replacement through an echocardiography laboratoryP581The role of echocardiography in the differential diagnosis of prolonged fever of unknown originP582Predictive value for paravalvular regurgitation of 3-dimensional anatomic aortic annulus shape assessed by multidetector computed tomography post-transcatheter aortic valve replacementP583The significance and advantages of echo and CT imaging & measurement at transcatherter aortic valve implantation through the left common carotid accessP584Comparison of the self-expandable Medtronic CoreValve versus the balloon-expandable Edwards SAPIEN bioprostheses in high-risk patients undergoing transfemoral aortic valve implantationP585The impact of transcatheter aortic valve implantation on mitral regurgitation severityP586Echocardiographic follow up of children with valvular lesions secondary to rheumatic heart disease: Data from a prospective registryP587Valvular heart disease and different circadian blood pressure profilesCardiomyopathiesP588Comparison of transthoracic echocardiography versus cardiac magnetic for implantable cardioverter defibrillator therapy in primary prevention strategy dilated cardiomyopathy patientsP589Incidence and prognostic significance of left ventricle reverse remodeling in a cohort of patients with idiopathic dilated cardiomyopathyP590Early evaluation of diastolic function in fabry diseaseP591Echocardiographic predictors of atrial fibrillation development in hypertrophic cardiomyopathyP592Altered Torsion mechanics in patients with hypertrophic cardiomyopathy: LVOT-obstruction is the topdog?P593Prevention of sudden cardiac death in hypertrophic cardiomyopathy: what has changed in the guidelines?P594Coronary microcirculatory function as determinator of longitudinal systolic left ventricular function in hypertrophic cardiomyopathyP595Detection of subclinical myocardial dysfunction by tissue Doppler ehocardiography in patients with muscular dystrophiesP596Speckle tracking myocardial deformation analysis and three dimensional echocardiography for early detection of chemotherapy induced cardiac dysfunction in bone marrow transplantation patientsP597Left ventricular non compaction or hypertrabeculation: distinguishing between physiology and pathology in top-level athletesP598Role of multi modality imaging in familiar screening of Danon diseaseP599Early impairment of global longitudinal left ventricular systolic function independently predicts incident atrial fibrillation in type 2 diabetes mellitusP600Fetal cardiovascular programming in maternal diabetes mellitus and obesity: insights from deformation imagingP601Longitudinal strain stress echo evaluation of aged marginal donor hearts: feasibility in the Adonhers project.P602Echocardiographic evaluation of left ventricular size and function following heart transplantation - Gender mattersSystemic diseases and other conditionsP603The impact of septal kinetics on adverse ventricular-ventricular interactions in pulmonary stenosis and pulmonary arterial hypertensionP604Improvement in right ventricular mechanics after inhalation of iloprost in pulmonary hypertensionP605Does the treatment of patients with metabolic syndrome correct the right ventricular diastolic dysfunction?P606Predictors of altered cardiac function in breast cancer survivors who were treated with anthracycline-based therapyP607Prevalence and factors related to left ventricular systolic dysfunction in asymptomatic patients with rheumatoid arthritis: a prospective tissue-doppler echocardiography studyP608Diastolic and systolic left ventricle dysfunction presenting different prognostic implications in cardiac amyloidosisP609Diagnostic accuracy of Bedside Lung Ultrasonography in Emergency (BLUE) protocol for the diagnosis of pulmonary embolismP610Right ventricular systolic dysfunction and its incidence in breast cancer patients submitted to anthracycline therapyP611Right ventricular dysfunction is an independent predictor of survival among cirrhotic patients undergoing liver transplantCongenital heart diseaseP612Hypoplasia or absence of posterior leaflet: a rare congenital anomaly of the mitral valveP613ECHO screening for Barlow disease in proband's relativesDiseases of the aortaP614Aortic size distribution and prognosis in an unselected population of patients referred for standard transthoracic echocardiographyP615Abdominal aorta aneurysm ultrasonographic screening in a large cohort of asympromatic volounteers in an Italian urban settingP616Thoracic aortic aneurysm and left ventricular systolic functionStress echocardiographyP617Wall motion score index, systolic mitral annulus velocity and left ventricular mass predicted global longitudinal systolic strain in 238 patients examined by stress echocardiographyP618Prognostic parameters of exercise-induced severe mitral valve regurgitation and exercise-induced systolic pulmonary hypertensionP619Risk stratification after myocardial infarction: prognostic value of dobutamine stress echocardiographyP620relationship between LV and RV myocardial contractile reserve and metabolic parameters during incremental exercise and recovery in healthy children using 2-D strain analysisP621Increased peripheral extraction as a mechanism compensatory to reduced cardiac output in high risk heart failure patients with group 2 pulmonary hypertension and exercise oscillatory ventilationP622Can exercise induced changes in cardiac synchrony predict response to CRT?Transesophageal echocardiographyP623Fully-automated software for mitral valve assessment in chronic mitral regurgitation by three-dimensional transesophageal echocardiographyP624Real-time 3D transesophageal echocardiography provides more accurate orifice measurement in percutaneous transcatheter left atrial appendage closureP625Percutaneous closure of left atrial appendage: experience of 36 casesReal-time three-dimensional TEEP626Real-time three-dimensional transesophageal echocardiography during pulmonary vein cryoballoon ablation for atrial fibrilationP627Three dimensional ultrasound anatomy of intact mitral valve and in the case of type 2 disfunctionTissue Doppler and speckle trackingP629Left ventricle wall motion tracking from echocardiographic images by a non-rigid image registrationP630The first experience with the new prototype of a robotic system for remote echocardiographyP631Non-invasive PCWP influence on a loop diuretics regimen monitoring model in ADHF patients.P632Normal range of left ventricular strain, dimensions and ejection fraction using three-dimensional speckle-tracking echocardiography in neonatesP633Circumferential ascending aortic strain: new parameter in the assessment of arterial stiffness in systemic hypertensionP634Aortic vascular properties in pediatric osteogenesis imperfecta: a two-dimensional echocardiography derived aortic strain studyP635Assessment of cardiac functions in children with sickle cell anemia: doppler tissue imaging studyP636Assessment of left ventricular function in type 1 diabetes mellitus patients by two-dimensional speckle tracking echocardiography: relation to duration and control of diabetesP637A study of left ventricular torsion in l-loop ventricles using speckle-tracking echocardiographyP638Despite No-Reflow, global and regional longitudinal strains assessed by two-dimensional speckle tracking echocardiography are predictive indexes of left ventricular remodeling in patients with STEMIP639The function of reservoir of the left atrium in patients with medicaly treated arterial hypertensionP640The usefulness of speckle tracking analysis for predicting the recovery of regional systolic function after myocardial infarctionP641Two dimensional speckle tracking echocardiography in assessment of left ventricular systolic function in patients with rheumatic severe mitral regurgitation and normal ejection fractionP642The prediction of left-main and tripple vessel coronary artery disease by tissue doppler based longitudinal strain and strain rate imagingP643Role of speckle tracking in predicting arrhythmic risk and occurrence of appropriate implantable defibrillator Intervention in patients with ischemic and non-ischemic cardiomyopathyComputed Tomography & Nuclear CardiologyP644Cardiac adrenergic activity in patients with nonischemic dilated cardiomyopathy. Correlation with echocardiographyP645Different vascular territories and myocardial ischemia, there is a gradient of association? Eur Heart J Cardiovasc Imaging 2015. [DOI: 10.1093/ehjci/jev278] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
49
|
Ruiz-Ortiz E, Gonzalez-Roca E, Mensa-Vilaro A, Rius J, Plaza S, Anton C, Calvo I, Modesto C, Anton J, Arnal C, Alvarez C, Alvarez-Coca J, Becerra E, Bilbao N, Camacho M, Crespo J, de Diego C, Diez-Garcia LF, Espinosa L, Garcia-Escriva D, de Gracia F, Gonzalez MI, Iglesias E, Izquierdo S, Lastra B, Llobet P, Lopez B, Lopez-Gonzalez V, Martinez R, Martin-Mateos MA, Merino R, Ortega L, Peiro ME, de Soto IP, Perez-Mendez C, Rodriguez-Valverde V, Ribes A, Ruiz A, Sanchez B, Santos JL, Sevilla B, Sotoca J, Vilas J, Villoria A, Yagüe J, Arostegui JI. Clinical and genetic features of Spanish patients with Mevalonate kinase deficiency. Pediatr Rheumatol Online J 2015. [PMCID: PMC4597073 DOI: 10.1186/1546-0096-13-s1-p36] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022] Open
|
50
|
Smith ZP, Hernández G, Gleason KL, Anand A, Doherty CM, Konstas K, Alvarez C, Hill AJ, Lozano AE, Paul DR, Freeman BD. Effect of polymer structure on gas transport properties of selected aromatic polyimides, polyamides and TR polymers. J Memb Sci 2015. [DOI: 10.1016/j.memsci.2015.06.032] [Citation(s) in RCA: 37] [Impact Index Per Article: 4.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|